All dysplastic lesions of the cervix uteri

N14_CERVICAL_DYSPLASIA_ALL

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule only females	293373
2. Check conditions None	293373
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — D06, N87 Hospital discharge: ICD-9 — 6221A\|6221B\|6221C\|2331A Cause of death: ICD-10 — D06, N87 Cause of death: ICD-9 — 6221A\|6221B\|6221C\|2331A 2 out of 7 registries used, show all original rules.	12059
4. Check minimum number of events None	12059
5. Include endpoints None	12059
6. Filter based on genotype QC (FinnGen only)	12059

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze: DF7

NAME	N14_CERVICAL_DYSPLASIA_ALL
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX	2
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	N870\|N871\|N872\|N879\|D060\|D061\|D067\|D069
HD_ICD_9	6221A\|6221B\|6221C\|2331A
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	N870\|N871\|N872\|N879\|D060\|D061\|D067\|D069
COD_ICD_9	6221A\|6221B\|6221C\|2331A
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to All dysplastic lesions of the cervix uteri based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	76103	76103	-
Only index persons	74438	74438	-
Unadjusted period prevalence (%)
Whole population	2.18	2.18	-
Only index persons	2.74	2.74	-
Median age at first event (years)
Whole population	-	34.69	-
Only index persons	-	34.52	-

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	12059	12059	-
Unadjusted period prevalence (%)	4.11	4.11	-
Median age at first event (years)	35.33	35.33	-

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
10697: Matched controls
106899

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

LDA10

NOMESCO Finland

Curettage of cervix uteri

22.8

323.0

3406

2145

LDB20

NOMESCO Finland

Electrocoagulation or laser therapy of cervix uteri

16.8

323.0

561

350

N87.9

ICD-10 Finland

Dysplasia of cervix uteri, unspecified

110.1

323.0

413

N87.2

ICD-10 Finland

Severe cervical dysplasia, not elsewhere classified

5519.0

323.0

3796

ULA02

NOMESCO Finland

Kolposcopy

51.7

323.0

8262

6579

8077/2-C53.9

ICD-O-3

Squamous intraepithelial neoplasia, high grade of cervix uteri

267.9

323.0

2314

110

ZXC00

NOMESCO Finland

Use of diathermy

55.1

323.0

490

A63.0

ICD-10 Finland

Anogenital (venereal) warts

6.7

323.0

1515

2555

R87.6

ICD-10 Finland

Abnormal findings in specimens from female genital organs, abnormal cytological findings

46.3

323.0

8128

6843

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

15.0

323.0

6457

9825

C539, 6666, 0

ICD-O-3

125.1

323.0

1131

101

D06.0

ICD-10 Finland

Carcinoma in situ: Endocervix

+∞

323.0

381

LDA20

NOMESCO Finland

Biopsy of vaginal cervix

34.9

323.0

6193

4049

N87.0

ICD-10 Finland

Mild cervical dysplasia

1546.3

323.0

4115

LDC03

NOMESCO Finland

Conisation of cervix uteri using diathermy or laser

164.0

323.0

6041

841

N87.1

ICD-10 Finland

Moderate cervical dysplasia

12995.6

323.0

3562

8326

FHL

Batch conization

108.3

307.1

336

LEB00

NOMESCO Finland

Biopsy of vagina

9.5

302.4

651

725

8070/2-C53.9

ICD-O-3

Squamous cell carcinoma in situ, NOS, of cervix uteri

51.0

265.0

322

D06.1

ICD-10 Finland

Carcinoma in situ: Exocervix

+∞

254.1

243

R87.5

ICD-10 Finland

Abnormal findings in specimens from female genital organs, abnormal microbiological findings

8.0

232.0

550

715

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.9

222.5

5222

35379

6221C

ICD-9 Finland

Noninflammatory disorders of cervix, Dysplasia of cervix (uteri)[DYSPLASIA CERVICIS UTERI GRAVIS]

+∞

217.3

208

G01AA10

ATC

clindamycin; vaginal

2.0

188.7

2908

16488

6221B

ICD-9 Finland

Noninflammatory disorders of cervix, Dysplasia of cervix (uteri)[DYSPLASIA CERVICIS UTERI MODERATA]

+∞

183.8

176

6221A

ICD-9 Finland

Noninflammatory disorders of cervix, Dysplasia of cervix (uteri)[DYSPLASIA CERVICIS UTERI LEVIS]

+∞

179.6

172

8140/2-C53.9

ICD-O-3

Adenocarcinoma in situ, NOS, of cervix uteri

220.1

147.3

152

LFB00

NOMESCO Finland

Biopsy of vulva or perineum

4.6

141.6

526

1196

8077/2-C53.1

ICD-O-3

Squamous intraepithelial neoplasia, high grade of exocervix

328.4

129.7

131

N89.0

ICD-10 Finland

Mild vaginal dysplasia

18.8

125.4

196

106

D06.9

ICD-10 Finland

Carcinoma in situ: Cervix, unspecified

+∞

124.1

119

LEB30

NOMESCO Finland

Destruction of lesion of vaginal mucosa

13.3

120.6

216

165

R87.7

ICD-10 Finland

Abnormal findings in specimens from female genital organs, abnormal histological findings

11.7

101.5

193

168

X86

ICPC

Abnormal cervix smear

5.4

101.5

322

616

2331A

ICD-9 Finland

Carcinoma in situ of breast and genito-urinary system, Cervix uteri

+∞

99.1

LCA06

NOMESCO Finland

Biopsy of endometrium

1.8

93.4

1861

11149

N89.1

ICD-10 Finland

Moderate vaginal dysplasia

28.8

83.4

114

D06BB04

ATC

podophyllotoxin; topical

2.2

80.3

935

4545

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.5

80.2

3401

24902

LDC00

NOMESCO Finland

Conisation of cervix uteri using knife

49.8

77.6

R87.2

ICD-10 Finland

Abnormal findings in specimens from female genital organs, abnormal level of other drugs, medicaments and biological substances

24.5

75.0

107

R87.1

ICD-10 Finland

Abnormal findings in specimens from female genital organs, abnormal level of hormones

29.6

67.2

P01AB01

ATC

metronidazole; oral, rectal

1.4

65.1

4510

36113

Z3231

NOMESCO Finland

Registered nurse

1.5

62.4

2341

16462

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.2

61.8

653

3027

R87.0

ICD-10 Finland

Abnormal findings in specimens from female genital organs, abnormal level of enzymes

21.9

59.1

N89.2

ICD-10 Finland

Severe vaginal dysplasia, not elsewhere classified

23.6

57.0

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.6

57.0

1778

11926

N90.0

ICD-10 Finland

Mild vulvar dysplasia

11.2

55.8

107

Z3232

NOMESCO Finland

Midwife

1.6

54.7

1772

11983

Z2221

NOMESCO Finland

Medical doctor

1.4

54.0

2999

22789

O04.9

ICD-10 Finland

Medical abortion, complete or unspecified, without complication

1.6

50.2

1599

10742

R87.9

ICD-10 Finland

Abnormal findings in specimens from female genital organs, unspecified abnormal finding

11.4

50.0

D06BB10

ATC

imiquimod; topical

2.3

48.9

495

2245

C53.11

ICD-10 Finland

Squamous cell carcinoma and exocervix

13.3

46.9

N87

ICD-10 Finland

Dysplasia of cervix uteri

26.6

44.1

TLC02

NOMESCO Finland

Simple extraction of IUD

1.8

42.2

756

4296

LFB20

NOMESCO Finland

Destruction of lesion of vulva or perineum

4.6

42.2

151

332

SPAT1193

SPAT

Pap smear

1.5

41.2

1738

12392

LDB10

NOMESCO Finland

Cryotherapy of cervix uteri

6.9

40.3

102

148

R2110

NOMESCO Finland

Giving the first information

1.7

40.1

916

5612

A63.8

ICD-10 Finland

Other specified predominantly sexually transmitted diseases

10.5

40.0

8325

FHL

Coagulation, cryo or laser in anesthesia or operating room

9.3

39.9

8077/2-C52.9

ICD-O-3

Squamous intraepithelial neoplasia, high grade of vagina, NOS

28.5

39.8

N90.1

ICD-10 Finland

Moderate vulvar dysplasia

10.8

38.6

0781C

ICD-9 Finland

Other diseases due to viruses and Chlamydiae, Viral warts[CONDYLOMA ACCUMINATUM]

5.2

38.3

121

233

N76.0

ICD-10 Finland

Acute vaginitis

1.6

37.2

1004

6435

X23

ICPC

Fear sexually transm dis female

1.7

36.8

851

5224

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.4

36.5

2491

19369

N07BA03

ATC

varenicline; oral

1.9

36.2

529

2796

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.4

34.3

1666

12166

N90.2

ICD-10 Finland

Severe vulvar dysplasia, not elsewhere classified

11.3

33.8

WX110

NOMESCO Finland

Local anesthesy

1.3

33.6

7172

65273

C53.01

ICD-10 Finland

Squamous cell carcinoma of the endocervix

10.9

33.3

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.3

32.3

2894

23396

8140/2-C53.0

ICD-O-3

Adenocarcinoma in situ, NOS, of endocervix

+∞

32.3

O34.4

ICD-10 Finland

Maternal care for other abnormalities of cervix

8.3

31.3

X92

ICPC

Chlamydia infection genital female

2.7

31.0

223

847

G01AF01

ATC

metronidazole; vaginal

1.5

30.9

1119

7679

LDB00

NOMESCO Finland

Excision of lesion of cervix uteri

2.9

30.7

194

679

8070/3-C53.9

ICD-O-3

Squamous cell carcinoma, NOS, of cervix uteri

10.8

30.6

N93.0

ICD-10 Finland

Postcoital and contact bleeding

3.3

29.6

152

462

8140/2-C53.1

ICD-O-3

Adenocarcinoma in situ, NOS, of exocervix

150.3

28.6

C53.02

ICD-10 Finland

Adenocarcinoma of the endocervix

9.5

28.2

J02AC01

ATC

fluconazole; systemic

1.3

28.2

5290

46831

8076/3-C53.9

ICD-O-3

Squamous cell carcinoma, microinvasive of cervix uteri

77.8

27.7

TLC00

NOMESCO Finland

Insertion of intrauterine device

1.5

27.7

1114

7811

TLW99

NOMESCO Finland

Other minor surgical procedure in gynaecology

2.2

26.7

265

1195

LCH11

NOMESCO Finland

Pharmacologic abortion

1.6

26.4

720

4612

N72

ICD-10 Finland

Inflammatory disease of cervix uteri

3.4

26.4

130

384

B97.7

ICD-10 Finland

Papillomavirus as the cause of diseases classified to other chapters

5.8

24.9

123

M03BX02

ATC

tizanidine; oral

1.2

24.6

6421

58575

A56.0

ICD-10 Finland

Chlamydial infection of lower genitourinary tract

2.3

23.8

231

1032

Z11.3

ICD-10 Finland

Special screening examination for infections with a predominantly sexual mode of transmission

1.5

23.7

783

5256

6500B

ICD-9 Finland

Delivery in a completely normal case[PARTUS SINE COMPLICATIONE]

1.3

23.5

2042

16310

N02AX02

ATC

tramadol; systemic, rectal

1.3

22.4

3079

26058

Z09.8

ICD-10 Finland

Follow-up examination after other treatment for other conditions

1.8

22.4

425

2457

K05.31

ICD-10 Finland

Periodontitis pronounced

1.6

22.3

540

3349

8140/3-C53.9

ICD-O-3

Adenocarcinoma, NOS, of cervix uteri

15.7

22.3

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

21.9

2104

17011

SPAT1308

SPAT

Sexual health counselling

1.3

21.9

2008

16141

SAA01

NOMESCO Finland

Simple examination of mouth

1.2

21.5

7515

70161

M01AE01

ATC

ibuprofen; systemic, rectal

1.4

21.4

9631

92832

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

1.5

21.2

808

5591

N02BE01

ATC

paracetamol; systemic, rectal

1.3

21.1

8402

79497

J01DB01

ATC

cefalexin; oral

1.3

20.9

8287

78300

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

20.2

521

3289

ZXD10

NOMESCO Finland

Scheduled procedure

1.2

20.0

3214

27607

Z20.2

ICD-10 Finland

Contact with and exposure to infections with a predominantly sexual mode of transmission

1.9

19.8

309

1677

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

1.3

19.6

1298

9930

M54.5

ICD-10 Finland

Low back pain

1.2

19.5

3121

26781

SPAT1283

SPAT

Restricted health certificate

1.3

19.4

2496

20897

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.5

19.0

767

5368

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.2

18.1

3620

31720

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

1.2

17.9

3638

31921

Z64.0

ICD-10 Finland

Problems related to unwanted pregnancy

1.6

17.6

435

2717

N93.9

ICD-10 Finland

Abnormal uterine and vaginal bleeding, unspecified

1.8

17.6

284

1562

8077/2-C51.9

ICD-O-3

Squamous intraepithelial neoplasia, high grade of vulva, NOS

9.7

17.6

W11

ICPC

Contraception oral

1.3

17.5

1289

10013

J01CA08

ATC

pivmecillinam; oral

1.2

17.4

5054

45821

X15

ICPC

Vaginal symptom/complaint other

1.6

17.3

479

3083

SDA04

NOMESCO Finland

Very demanding parodonthologic therapy

1.2

16.9

2191

18306

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.2

16.3

4055

36174

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.7

16.2

365

2224

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.2

16.2

4879

44269

J01AA02

ATC

doxycycline; systemic

1.2

16.0

7415

69854

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.2

16.0

5208

47560

SAA02

NOMESCO Finland

Basic examination of mouth

1.2

15.8

6913

64729

XLA10

NOMESCO Finland

1.5

15.5

571

3922

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.2

15.4

5415

49696

SAA03

NOMESCO Finland

Extended examination of mouth

1.2

15.2

3820

34037

Z72.0

ICD-10 Finland

Tobacco use

2.0

15.1

204

1055

K02.1

ICD-10 Finland

Caries of dentine

1.2

15.0

5901

54611

Z30.4

ICD-10 Finland

Surveillance of contraceptive drugs

1.3

15.0

968

7359

LCD31

NOMESCO Finland

Radical laparoscopic hysterectomy

7.7

15.0

WX290

NOMESCO Finland

Other blockade of nerve

1.2

15.0

4858

44236

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.2

14.9

5269

48328

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

1.6

14.7

420

2725

J05AB01

ATC

aciclovir; systemic

1.2

14.6

1952

16327

O47.0

ICD-10 Finland

False labour before 37 completed weeks of gestation

1.3

14.6

1383

11103

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

1.6

14.5

344

2128

8010/2-C53.9

ICD-O-3

Carcinoma in situ, NOS, of cervix uteri

150.1

14.5

Z30.0

ICD-10 Finland

General counselling and advice on contraception

1.3

14.4

916

6949

LFB10

NOMESCO Finland

Excision of lesion of vulva or perineum

2.4

14.4

120

503

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.2

14.0

3577

31862

R87.3

ICD-10 Finland

Abnormal findings in specimens from female genital organs, abnormal level of substances chiefly nonmedicinal as to source

15.7

13.9

8111

FHL

Taking a biopsy from the mouth of the uterus at the operating room or under anesthesia (vulvabiopsia 8474, vaginabiopsia 8411)

6.8

13.8

N05CF01

ATC

zopiclone; oral

1.2

13.7

2224

18983

LCD01

NOMESCO Finland

Total laparoscopic hysterectomy

1.7

13.7

302

1833

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.4

13.6

800

5992

Z30.2

ICD-10 Finland

Sterilization

1.3

13.5

1258

10072

R74

ICPC

Upper respiratory infection acute

1.2

13.4

3406

30298

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.2

13.3

5909

54958

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

1.2

13.1

2310

19869

T36

ICD-10 Finland

Poisoning by systemic antibiotics

1.5

12.9

414

2760

N06AX11

ATC

mirtazapine; oral

1.2

12.9

2677

23374

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

1.3

12.8

872

6681

1390

FHL

Colposcopy

5.7

12.6

7950A

ICD-9 Finland

Nonspecific abnormal histological and immunological findings, Nonspecific abnormal Papanicolaou smear of cervix

8.2

12.5

ULC02

NOMESCO Finland

Hysteroscopy

1.4

12.4

550

3923

D82

ICPC

Teeth/gum disease

1.2

12.4

3502

31370

EBA00

NOMESCO Finland

Extraction of tooth

1.2

12.3

2695

23618

N73.9

ICD-10 Finland

Female pelvic inflammatory disease, unspecified

1.7

12.3

239

1400

SPAT1312

SPAT

General health counselling

1.2

12.2

2845

25064

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.8

12.2

220

1260

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.8

12.2

214

1215

N02AJ06

ATC

codeine and paracetamol; systemic

1.2

12.2

3157

28072

Z30.1

ICD-10 Finland

Insertion of (intrauterine) contraceptive device

1.2

12.1

1949

16589

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.2

12.1

2817

24816

R87.8

ICD-10 Finland

Abnormal findings in specimens from female genital organs, other abnormal findings

3.3

12.1

184

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.2

12.0

5826

54355

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

2.6

11.9

315

L04AX01

ATC

azathioprine; systemic

1.6

11.7

328

2124

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

11.6

7163

67951

LCD04

NOMESCO Finland

Laparoscopic hysterectomy

1.5

11.5

389

2628

LDA96

NOMESCO Finland

Other biopsy of cervix uteri

11.1

11.5

J01DA01

ATC

[U] cefalexin; systemic

1.2

11.5

6060

56794

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.2

11.4

1804

15322

X91

ICPC

Condylomata acuminata female

3.6

11.4

140

LCD10

NOMESCO Finland

Vaginal hysterectomy

1.6

11.3

301

1922

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

2.0

11.3

135

669

8327

FHL

Amputation portionis and conization

35.0

11.2

SPAT1249

SPAT

Treatment-related counselling outside office

1.2

11.2

3705

33523

M03BC01

ATC

orphenadrine (citrate); systemic

1.2

11.1

2333

20344

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.2

10.9

3415

30765

Z5132

NOMESCO Finland

Nursing associate professional

3.3

10.8

162

65000

ICD-8 Finland

Delivery without mention of complication, Occipital presentation

1.2

10.8

1537

12911

C53.12

ICD-10 Finland

Adenocarcinoma of the exocervix

9.6

10.7

SCA01

NOMESCO Finland

Simple analysis and advice of nutrition with regard to dentistry

1.2

10.5

2735

24267

LAF11

NOMESCO Finland

Laparoscopic bilateral salpingo-oophorectomy

1.5

10.4

341

2288

PJD64

NOMESCO Finland

Laparoscopic dissection of iliac lymph nodes

2.8

10.4

232

LDC96

NOMESCO Finland

Other excision of cervix uteri

23.3

10.2

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.1

10.2

3900

35601

8474

FHL

Coagulation, excision, or biopsy of local change (eg, condyloma, tumor) in operating room or anesthesia

3.4

10.2

138

J05AB11

ATC

valaciclovir; oral

1.3

10.0

1091

8898

P01BA02

ATC

hydroxychloroquine; oral

1.3

9.9

636

4834

LCH13

NOMESCO Finland

Vacuum aspiration from uterus after medically induced abortion

1.6

9.9

239

1495

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.2

9.9

1464

12342

8070/3-C53.1

ICD-O-3

Squamous cell carcinoma, NOS, of exocervix

12.2

9.8

M01AE03

ATC

ketoprofen; systemic, rectal

1.2

9.8

2798

24977

R05

ICPC

Cough

1.2

9.8

1868

16127

SDA02

NOMESCO Finland

Parodonthologic therapy

1.2

9.8

3084

27741

N88.2

ICD-10 Finland

Stricture and stenosis of cervix uteri

4.4

9.8

SPAT1263

SPAT

Sampling

1.1

9.8

3790

34604

A60.0

ICD-10 Finland

Herpesviral infection of genitalia and urogenital tract

1.6

9.7

216

1320

8411

FHL

Local change laser, coagulation, biopsy or removal

4.2

9.6

N06AB04

ATC

citalopram; systemic

1.2

9.6

1860

16079

Z09.9

ICD-10 Finland

Follow-up examination after unspecified treatment for other conditions

1.9

9.5

127

659

M79.6

ICD-10 Finland

Pain in limb

1.2

9.4

2975

26750

D19

ICPC

Teeth/gum symptom/complaint

1.2

9.4

2472

21917

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.3

9.4

985

7995

D06.7

ICD-10 Finland

Carcinoma in situ: Other parts of cervix

+∞

9.4

MCA10

NOMESCO Finland

Lower uterine segment caesarean section

0.8

9.4

1184

14063

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

1.2

9.3

2413

21375

M01AB05

ATC

diclofenac; systemic, rectal

1.1

9.3

6157

58176

WX408

NOMESCO Finland

General anesthesy, balanced

1.2

9.2

1960

17073

W14

ICPC

Contraception female other

1.3

9.2

670

5185

J01MA02

ATC

ciprofloxacin; systemic

1.2

9.2

2654

23698

Z71.8

ICD-10 Finland

Other specified counselling

1.2

9.1

2239

19739

M54.4

ICD-10 Finland

Lumbago with sciatica

1.2

9.1

1337

11255

PJA01

NOMESCO Finland

Laparoscopic sentinel node excision

3.3

9.1

135

Z2446

NOMESCO Finland

Social worker

1.4

9.0

448

3268

Z01.2

ICD-10 Finland

Dental examination

1.1

9.0

4014

36930

X85

ICPC

Cervical disease NOS

5.6

9.0

LDC10

NOMESCO Finland

Partial excision of cervix uteri

7.4

8.9

A03

ICPC

Fever

1.2

8.9

1587

13615

LCH00

NOMESCO Finland

Vacuum aspiration of products of conception from uterus

1.4

8.9

414

2988

N30.0

ICD-10 Finland

Acute cystitis

1.2

8.9

1173

9768

4044

NOMESCO Finland

5.7

8.9

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.3

8.8

863

6952

LCA13

NOMESCO Finland

Curettage of cervix and body of uterus

1.4

8.8

392

2806

21899

ICD-8 Finland

Uterine fibroma

0.3

8.8

616

N76.1

ICD-10 Finland

Subacute and chronic vaginitis

1.6

8.7

244

1585

SPAT1301

SPAT

No procedures

1.2

8.7

2335

20714

Z87.4

ICD-10 Finland

Personal history of diseases of the genitourinary system

2.0

8.7

111

570

ZXC10

NOMESCO Finland

Use of laser

1.8

8.7

137

757

A02BC02

ATC

pantoprazole; systemic

1.1

8.7

5392

50637

6350C

ICD-9 Finland

Legally induced abortion, Complicated by genital tract and pelvic infection[ABORTUS PROV LEGAL SINE COMPL,SOSIAALISET SYYT]

1.3

8.6

528

3986

ZXE00

NOMESCO Finland

One hour or less

1.1

8.6

3611

33065

R51.80

ICD-10 Finland

Headache

1.2

8.6

1453

12396

SDE04

NOMESCO Finland

Periodontal treatment by dental hygienist, very extensive

1.3

8.6

776

6185

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

1.3

8.6

650

5063

T74.1

ICD-10 Finland

Physical abuse

1.7

8.6

177

1063

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.2

8.5

928

7563

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.2

8.5

1410

12008

W12

ICPC

Contraception intrauterine

1.2

8.4

1500

12862

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

1.2

8.4

1624

14026

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.2

8.4

2452

21893

SPAT1192

SPAT

Gynaecological examination

1.2

8.4

1501

12875

X14

ICPC

Vaginal discharge

1.5

8.3

277

1875

WZA90

NOMESCO Finland

Other doctors statement

1.2

8.3

1881

16465

J01FF01

ATC

clindamycin; systemic

1.2

8.2

2089

18448

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.2

8.2

2182

19336

R21

ICPC

Throat symptom/complaint

1.2

8.2

2250

19988

M03BC51

ATC

orphenadrine, combinations; systemic

1.1

8.1

2617

23525

P01

ICPC

Feeling anxious/nervous/tense

1.2

8.0

1182

9950

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.2

8.0

1198

10100

D01

ICPC

Abdominal pain/cramps general

1.2

7.9

912

7483

C53.00

ICD-10 Finland

Malignant tumor of endocervix without histology

7.7

7.8

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.1

7.8

3446

31606

ZXE20

NOMESCO Finland

More than three and less than five hours

1.3

7.7

731

5861

J01EA01

ATC

trimethoprim; systemic

1.1

7.7

2408

21578

P17

ICPC

Tobacco abuse

1.9

7.7

107

569

8077/2-C53.0

ICD-O-3

Squamous intraepithelial neoplasia, high grade of endocervix

45.0

7.7

G01AX03

ATC

policresulen; vaginal

2.0

7.7

440

X29

ICPC

Genital sympt/compl female other

1.7

7.7

137

789

KAY40

NOMESCO Finland

0.6

7.6

107

1789

H02AB06

ATC

prednisolone; systemic

1.1

7.6

3740

34528

8140/3-C53.0

ICD-O-3

Adenocarcinoma, NOS, of endocervix

8.0

7.6

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

3.0

7.6

138

XQ900

NOMESCO Finland

Photography of physically assaulted person

11.8

7.6

ZX040

NOMESCO Finland

Intracavity HDR radiotherapy

4.2

7.6

D11

ICPC

Diarrhoea

1.2

7.5

1079

9055

J01FA10

ATC

azithromycin; systemic

1.1

7.5

6103

57996

EMB10

NOMESCO Finland

Tonsillectomy

1.3

7.5

677

5399

XXA00

NOMESCO Finland

Clinical examination requiring general anaesthesia

2.7

7.5

168

O34.3

ICD-10 Finland

Maternal care for cervical incompetence

2.1

7.5

358

N05BA04

ATC

oxazepam; oral

1.2

7.4

2082

18507

D10

ICPC

Vomiting

1.3

7.4

630

4986

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.2

7.4

774

6283

WX002

NOMESCO Finland

Sedation and analgesia

1.2

7.4

1149

9722

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.3

7.4

671

5359

Z30.8

ICD-10 Finland

Other contraceptive management

1.4

7.4

294

2065

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

1.3

7.3

751

6082

N86

ICD-10 Finland

Erosion and ectropion of cervix uteri

2.6

7.3

188

PJ5AQ

NOMESCO Finland

Sentinell lymphnode SPECT with low dose CT

3.9

7.3

T810, N872

ICD-10 Finland

+∞

7.3

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.3

7.2

671

5374

6440A

ICD-9 Finland

Early or threatened labour, Threatened premature labour[PARTUS PRAEMATURUS IMMINENS]

1.6

7.2

175

1104

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.2

7.2

957

7978

JN2DG

NOMESCO Finland

Very extensive MRI examination of lower part of abdoment with high intensity magnet

2.0

7.2

399

AA1AD

NOMESCO Finland

CT of head and brain

1.2

7.2

1115

9433

M01AH05

ATC

etoricoxib; oral

1.1

7.1

5304

50080

O04.6

ICD-10 Finland

Medical abortion, complete or unspecified, complicated by delayed or excessive haemorrhage

1.7

7.1

146

877

8113

FHL

Fractional scraping

1.5

7.1

261

1803

KMAK

NOMESCO Finland

1.1

7.1

5619

53231

K05.30

ICD-10 Finland

Periodontitis complex

1.3

7.1

693

5581

B02AA02

ATC

tranexamic acid; systemic

1.2

7.1

1679

14729

TPH04

NOMESCO Finland

Cathetrisation of vein

1.2

7.1

1269

10878

R87.4

ICD-10 Finland

Abnormal findings in specimens from female genital organs, abnormal immunological findings

7.9

7.1

8323

FHL

Suturation

12.0

7.1

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.1

7.0

2399

21615

L03

ICPC

Low back symptom/complaint

1.2

7.0

2018

17966

LBE20

NOMESCO Finland

Laparoscopic bilateral salpingectomy

1.5

7.0

192

1246

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.2

7.0

955

7980

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.2

6.8

1459

12698

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

1.5

6.8

187

1215

SGC10

NOMESCO Finland

Covering pulpa of tooth

1.2

6.8

893

7430

F41.09

ICD-10 Finland

UNS Panic Syndrome

1.4

6.7

280

1985

M32.1

ICD-10 Finland

Systemic lupus erythematosus with organ or system involvement

3.8

6.7

F43.20

ICD-10 Finland

Adaptation disorder with short-term depression

1.7

6.7

137

827

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

1.3

6.6

654

5273

M01AE02

ATC

naproxen; oral, rectal

1.1

6.6

5455

51706

ZXC96

NOMESCO Finland

Robot assisted procedure

1.9

6.6

427

N93.8

ICD-10 Finland

Other specified abnormal uterine and vaginal bleeding

1.6

6.6

179

1160

Z00.0

ICD-10 Finland

General medical examination

1.2

6.5

1256

10831

C53.09

ICD-10 Finland

Malignant tumor of endocervix, unspecified histology

10.0

6.5

O63.0

ICD-10 Finland

Prolonged first stage (of labour)

0.7

6.5

149

2238

LGA21

NOMESCO Finland

Laparoscopic sterilisation by constriction of Fallopian tubes

1.3

6.5

605

4847

YX9VG

NOMESCO Finland

Other MRI eamination with high intensity magnet for dose design of radiotherapy

6.8

6.5

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

1.2

6.5

1326

11496

8112

FHL

Scraping the cervix

4.5

6.4

ZX120

NOMESCO Finland

Intravenous

1.3

6.4

548

4341

KAY20

NOMESCO Finland

0.6

6.4

1390

M25.5

ICD-10 Finland

Pain in joint

1.1

6.4

2531

22999

Z3226

NOMESCO Finland

Physiotherapist

1.2

6.4

1238

10685

O04.1

ICD-10 Finland

Medical abortion, incomplete, complicated by delayed or excessive haemorrhage

1.7

6.4

118

693

O34.2

ICD-10 Finland

Maternal care due to uterine scar from previous surgery

0.8

6.3

587

7198

C53.1

ICD-10 Finland

Malignant neoplasm: Exocervix

11.0

6.3

N06AX16

ATC

venlafaxine; oral

1.2

6.2

1338

11641

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.1

6.2

1915

17123

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

1.9

6.2

445

N06AB06

ATC

sertraline; oral

1.2

6.2

994

8440

K50.8

ICD-10 Finland

Other Crohn disease

1.7

6.2

114

668

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.3

6.2

436

3374

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.2

6.1

1692

15004

A51.3

ICD-10 Finland

Secondary syphilis of skin and mucous membranes

5.3

6.1

N06AB10

ATC

escitalopram; oral

1.1

6.1

2083

18745

R03AC02

ATC

salbutamol; inhalant

1.1

6.1

5015

47445

8070/3-C53.0

ICD-O-3

Squamous cell carcinoma, NOS, of endocervix

12.5

6.1

N07BB01

ATC

disulfiram; oral

1.5

6.1

217

1498

N03AX16

ATC

pregabalin; oral

1.2

6.0

1603

14176

MA1AE

NOMESCO Finland

Ultrasound examination of early pregnancy (before 12. postmenstrual week)

1.2

6.0

1552

13695

L02

ICPC

Back symptom/complaint

1.2

6.0

736

6084

SPAT1153

SPAT

Removal of sutures

1.1

6.0

1989

17862

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(40768804) Tissue Pathology biopsy report

6653

43816

2.15

307.65

2.6

1.9

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

2721

6238

5.33

307.65

2.3

1.2

—

(3025130) Human papilloma virus identified in Specimen

2145

2253

11.34

307.65

2.3

1.4

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

793

532

15.85

307.65

2.4

1.5

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

6735

32696

3.39

307.65

2.4

1.4

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

3806

25241

1.74

157.10

2.4

2.0

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

3429

22420

1.74

146.95

2.3

1.9

—

(4035726)

1236

7022

1.84

80.50

1.4

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

2397

16882

1.52

66.65

2.1

1.8

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1904

12901

1.56

62.76

1.9

1.7

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

223

4.10

33.27

1.5

2.1

ug/l

6.5

3.9

0.21

132

(46235355) HIV 1 and 2 tests - Meaningful Use set

4010

34711

1.23

23.40

2.1

2.0

—

(3031040) Bacteria [#/volume] in Urine by Automated count

7433

68449

1.22

23.06

4.0

3.9

e6/l

1883.0

1890.3

0.00

722

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1054

7688

1.40

22.35

1.6

1.5

—

(3037467) Urinalysis macro (dipstick) panel - Urine

7672

71018

1.21

21.96

4.2

3.9

—

(3013707) Erythrocyte sedimentation rate by Westergren method

8000

74819

1.20

18.63

4.0

3.7

mm/h

9.7

9.9

0.92

7560

70577

(3011397) Hemoglobin [Presence] in Urine by Test strip

2690

22818

1.23

18.12

3.3

—

(3035350) Ketones [Presence] in Urine by Test strip

5611

51004

1.18

17.70

3.3

3.2

estimate

0.0

0.26

1096

10088

(3009261) Glucose [Presence] in Urine by Test strip

5673

51641

1.18

17.53

3.4

3.3

estimate

0.0

0.63

1110

10252

(3018095) Leukocytes [#/volume] in Urine

3637

31869

1.20

17.38

3.4

3.2

e6/l

58.9

76.2

1.57

2350

20652

(3021601) Nitrite [Presence] in Urine by Test strip

5631

51253

1.18

17.35

4.5

4.4

estimate

0.0

0.16

1130

10397

(3023103) Potassium [Moles/volume] in Serum or Plasma

10306

99088

1.26

17.10

10.4

9.9

mmol/l

3.9

0.16

10007

96289

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

9748

93163

1.23

17.02

9.1

8.7

ml/min/173m2

91.9

91.6

0.78

7939

76077

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

7606

71067

1.18

16.90

7.0

6.6

u/l

71.2

72.5

2.29

7150

67223

(3019550) Sodium [Moles/volume] in Serum or Plasma

10276

98792

1.26

16.89

10.3

9.8

mmol/l

139.5

139.6

1.87

10000

96238

(42870588) Differential panel, method unspecified - Blood

3571

31467

1.19

15.64

6.1

5.7

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1623

13234

1.26

15.43

2.4

2.3

e6/l

1.0

1.2

0.66

872

7016

(3006315) Basophils [#/volume] in Blood

5473

50032

1.17

15.14

6.0

5.6

e9/l

0.0

0.11

4846

44314

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1527

12413

1.26

14.87

2.6

2.5

e6/l

4.6

5.1

0.80

781

6241

(3001604) Monocytes [#/volume] in Blood

5449

49865

1.16

14.70

6.0

5.6

e9/l

0.5

0.16

4848

44274

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

10696

103598

1.27

14.62

11.1

10.2

mg/l

18.8

18.4

0.50

8279

79612

(3002256) Pathology report gross observation

1623

13314

1.25

14.58

1.2

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1976

16575

1.23

14.43

1.7

1.6

—

(3030467) Casts [#/volume] in Urine by Automated count

2627

22711

1.20

13.98

2.9

2.7

e6/l

0.3

0.48

1911

16556

(3013115) Eosinophils [#/volume] in Blood

5632

51919

1.15

13.20

6.2

5.8

e9/l

0.2

0.19

5121

46797

(36304419) Bacteria [Presence] in Urine

2625

22830

1.19

12.91

2.8

2.6

—

(3006504) Eosinophils/100 leukocytes in Blood

5108

46808

1.15

12.89

6.1

5.6

2.7

2.8

0.47

4778

43887

(3002582) Erythrocytes [#/volume] in Urine

2850

24996

1.18

12.66

2.9

2.7

e6/l

34.2

73.1

2.74

2107

18584

(3019198) Lymphocytes [#/volume] in Blood

5610

51831

1.15

12.45

6.0

5.6

e9/l

2.0

0.36

5105

46893

(3019069) Monocytes/100 leukocytes in Blood

5123

47044

1.15

12.37

6.4

5.8

7.9

0.23

4827

44506

(3022096) Basophils/100 leukocytes in Blood

4930

45154

1.15

12.34

6.3

5.7

0.7

0.52

4605

42343

(3013650) Neutrophils [#/volume] in Blood by Automated count

6151

57232

1.15

12.26

8.4

8.3

e9/l

4.0

3.9

0.31

5439

50670

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

11066

107981

1.27

11.72

9.1

8.5

u/l

23.8

23.9

0.18

10771

105076

(3018010) Neutrophils/100 leukocytes in Blood

5230

48352

1.14

10.95

5.9

5.4

56.3

56.5

0.99

4916

45710

(40758558) Short blood count panel - Blood

2749

24283

1.17

10.93

6.2

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

10934

106653

1.25

10.84

11.4

10.7

umol/l

66.3

66.1

0.49

10929

106595

(3021589) Normoblasts [#/volume] in Blood

4819

44331

1.14

10.84

8.2

8.0

e9/l

0.0

4.91

3969

36477

(3002030) Lymphocytes/100 leukocytes in Blood

5285

48984

1.14

10.47

6.1

5.6

29.9

29.8

0.56

4955

46156

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

4923

45447

1.14

10.33

5.3

5.2

umol/l

9.3

9.5

1.14

4615

42827

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

360

2.23

10.22

1.4

1.1

—

(40761511) CBC panel - Blood by Automated count

11223

109938

1.27

9.77

10.0

9.7

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

3883

35404

1.14

9.68

5.0

4.8

mmol/l

1.2

0.49

3559

32404

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1592

13578

1.20

9.49

1.7

1.6

1.4

1.3

2.03

1422

12299

(3033658) Prothrombin time (PT) actual/Normal

2500

22155

1.16

9.32

3.7

3.3

97.3

98.7

2.38

2424

21448

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

1360

11463

1.21

9.20

2.2

u/l

3994.9

6107.1

2.08

526

4776

(3044640) Blood type and Crossmatch panel - Blood

3477

31559

1.14

9.18

2.1

1.9

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

4321

39770

1.13

9.16

5.7

5.4

mmol/l

1.2

0.90

3706

33658

(3026008) Bacteria identified in Urine by Culture

3127

28296

1.14

8.53

2.5

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

947

7763

1.24

8.44

1.7

—

(3044889) 12 lead EKG panel

6500

61501

1.12

8.28

2.8

—

(3029937) Albumin [Presence] in Urine by Test strip

2996

27079

1.14

8.28

3.7

3.5

estimate

0.0

0.30

1134

10296

(3011288) Drugs identified in Urine by Screen method

585

4560

1.29

7.99

3.5

2.8

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

2379

21235

1.15

7.87

1.3

u/ml

10.8

9.3

0.53

965

9170

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

10191

99227

1.16

7.79

5.1

mu/l

1.9

2.0

0.04

9668

94434

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2573

23162

1.14

7.45

2.0

1.9

—

(3028707) Methadone [Presence] in Urine by Screen method

378

2802

1.36

7.37

3.1

2.6

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

3600

33115

1.12

7.29

1.7

1.8

pmol/l

98.8

99.7

0.60

1968

17643

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

155

2.58

7.21

1.1

1.2

—

(3023511) Choriogonadotropin [Units/volume] in Urine

728

5903

1.25

7.20

1.4

1.3

—

(3019150) Specific gravity of Urine by Refractometry

2412

21673

1.14

7.15

3.5

kg/l

1.0

1.10

337

3397

(3045414) Leukocytes [Presence] in Urine

575

4550

1.27

7.01

1.7

—

(3018418) pH of Serum or Plasma

2633

23825

1.13

6.97

3.9

3.5

7.4

0.47

469

4614

(3026782) Osmolality of Urine

1798

15881

1.15

6.83

2.7

2.4

mosm/kgh2o

512.0

521.7

1.05

1528

13484

(3025941) Bacteria identified in Stool by Culture

852

7074

1.22

6.74

1.3

1.2

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

7674

73657

1.11

6.72

2.9

2.7

u/l

34.0

33.7

0.15

7356

70503

(3048689) Calprotectin [Mass/mass] in Stool

1837

16274

1.15

6.68

2.5

2.4

ug/g

100.5

100.1

0.02

1419

12738

(3024731) MCV [Entitic volume]

11788

116602

1.39

6.66

16.4

15.4

90.7

90.2

40.22

11687

115644

(3035941) MCH [Entitic mass]

11787

116591

1.39

6.65

16.4

15.4

30.2

30.0

43.91

11688

115631

(3026361) Erythrocytes [#/volume] in Blood

11788

116612

1.39

6.55

16.4

15.5

e12/l

4.4

4.5

14.16

11561

114455

(3010813) Leukocytes [#/volume] in Blood

11789

116642

1.38

6.36

16.5

15.5

e9/l

6.8

6.7

3.25

11564

114420

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

5298

49998

1.10

6.36

3.8

—

(3007461) Platelets [#/volume] in Blood

11776

116497

1.37

6.32

16.5

15.5

e9/l

269.7

269.5

0.13

11564

114472

(3000963) Hemoglobin [Mass/volume] in Blood

11789

116654

1.38

6.24

16.5

15.5

g/l

133.1

133.0

0.89

11694

115692

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

9134

88639

1.12

6.13

4.4

pmol/l

14.3

0.18

8607

83613

(3024561) Albumin [Mass/volume] in Serum or Plasma

3807

35394

1.11

6.09

4.5

4.2

g/l

36.8

36.7

0.45

3576

33028

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

4301

40237

1.10

6.08

3.4

3.3

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2443

22170

1.12

6.07

1.3

iu/ml

39.0

28.6

0.37

781

6954

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1200

10375

1.17

6.04

3.0

2.3

umol/l

5.6

6.0

0.53

992

8677

(3016879) Cocaine [Presence] in Urine

723

5977

1.22

6.00

2.6

2.0

—

(3000764) Benzodiazepines [Presence] in Urine

782

6530

1.21

5.86

2.5

1.9

—

(3028300) Cannabinoids [Presence] in Urine

786

6576

1.21

5.78

2.5

1.9

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1226

10659

1.16

5.75

1.5

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3636

33807

1.10

5.74

3.3

3.0

u/l

30.2

29.3

0.25

3454

32363

(3002385) Erythrocyte distribution width [Ratio]

9317

90615

1.11

5.70

13.3

12.4

13.5

0.53

9154

88972

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1057

9091

1.18

5.68

4.8

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

444

3500

1.28

5.66

1.5

—

(3000850) Epithelial cells [#/volume] in Urine

1943

17461

1.13

5.64

2.4

2.3

e6/l

8.9

8.5

0.31

1666

15081

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

2.82

5.63

1.3

—

(4198724)

588

1.67

5.50

4.1

2.1

—

(3027008) Opiates [Presence] in Urine

781

6563

1.20

5.49

2.2

1.9

—

(3037522) Nuclear Ab [Titer] in Serum

1893

17016

1.13

5.47

1.4

titre

549.8

571.9

0.19

406

3431

(1001926) Buprenorphine [Presence] in Urine by Screen method

614

5044

1.23

5.45

2.7

2.0

—

(3014051) Protein [Presence] in Urine by Test strip

286

2141

1.34

5.35

1.9

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

3070

28399

1.11

5.29

2.4

u/l

53.1

56.8

6.66

2848

26386

(3000093) Morphology [Interpretation] in Blood Narrative

565

1.67

5.26

1.1

1.2

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

1015

8765

1.17

5.20

2.2

2.8

u/ml

45.2

36.9

0.27

980

8488

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

986

8514

1.17

5.06

2.4

2.3

u/l

37.3

35.8

0.13

830

7278

(3027944) Amphetamines [Presence] in Urine

764

6473

1.19

4.93

2.4

1.9

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

9652

94246

1.11

4.89

3.5

mmol/l

5.6

1.93

9064

88794

(3007853) Bacteria identified in Skin by Aerobe culture

1248

11003

1.15

4.84

1.6

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

485

5890

0.81

4.66

1.4

—

(3022145) Colonoscopy Study observation

1171

10312

1.15

4.63

1.4

1.3

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

533

4398

1.22

4.58

1.4

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2462

22667

1.11

4.58

1.8

2.0

u/l

157.1

139.3

0.40

2346

21482

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

3202

29856

1.10

4.57

1.7

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1568

14102

1.13

4.47

2.4

2.5

mmol/l

2.4

0.30

1348

12324

(3019832) Treponema pallidum Ab [Presence] in Serum

2628

24311

1.10

4.42

1.7

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

322

2521

1.28

4.42

1.5

1.6

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

350

2770

1.27

4.41

5.0

4.2

mmol/l

24.2

0.04

317

2469

(3000991) Gas panel - Venous blood

575

4809

1.20

4.32

8.3

7.8

—

(3013762) Body weight Measured

4.54

4.28

1.0

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

282

1.84

4.22

3.4

2.7

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1273

11351

1.13

4.18

1.7

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

3125

29224

1.09

4.12

1.3

u/ml

1.7

1.4

0.47

943

8677

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

463

3822

1.22

4.01

1.3

1.4

u/l

23.6

24.4

0.25

365

3167

(3007164) IgA [Mass/volume] in Serum or Plasma

2627

24407

1.09

3.99

1.4

g/l

2.2

2.1

1.75

1612

15700

(3023323) Follitropin [Units/volume] in Serum or Plasma

1419

12779

1.12

3.96

1.3

iu/l

25.3

26.2

0.53

1251

11167

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

426

3496

1.22

3.92

1.7

1.6

iu/ml

0.1

5.6

0.56

648

(21494815) CD4 cells/100 lymphocytes in Specimen

117

798

1.47

3.88

2.5

2.0

43.9

46.1

0.23

135

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1475

13333

1.12

3.86

2.8

ng/l

195.9

289.4

1.20

765

6901

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

639

1.52

3.81

2.9

2.6

e6/l

765.2

885.9

0.80

304

(3015377) Calcium [Moles/volume] in Serum or Plasma

3132

29383

1.09

3.78

3.0

3.1

mmol/l

2.3

0.19

2821

26491

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

446

3696

1.21

3.74

1.6

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

236

1.86

3.74

1.1

1.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

236

1.86

3.74

1.1

1.4

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

8714

85005

1.08

3.69

4.1

4.2

mmol/mol

36.9

37.5

10.73

8222

80600

(3005719) IgG [Mass/volume] in Serum or Plasma

852

7461

1.15

3.69

2.6

2.5

g/l

10.5

10.4

0.54

785

6837

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

627

7271

0.85

3.68

1.7

1.8

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

447

1.61

3.67

2.8

2.7

42.1

44.5

0.23

175

(3022621) pH of Urine by Test strip

727

6296

1.16

3.66

2.5

2.6

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

709

8139

0.86

3.65

1.4

1.5

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

10126

99457

1.10

3.57

3.7

mmol/l

2.9

0.45

9594

94252

(3042936) Bacteria identified in Isolate by Culture

1277

11503

1.12

3.56

1.8

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

834

7315

1.15

3.54

1.5

—

(40761535) Cells panel - Urine sediment

730

6356

1.16

3.44

3.4

3.3

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

268

2123

1.27

3.44

3.1

3.4

u/ml

231.9

359.3

0.39

226

1803

(3021960) Folate [Moles/volume] in Serum or Plasma

1899

17504

1.10

3.40

1.5

nmol/l

21.5

21.1

0.47

1677

15537

(3000492) Spirometry study

1134

10183

1.12

3.34

1.3

1.4

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2924

27485

1.08

3.31

2.5

ng/l

25.4

56.4

0.58

1176

11702

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

436

3652

1.20

3.31

1.3

u/ml

39.7

33.0

0.34

254

(3035320) C reactive protein [Mass/volume] in Body fluid

107

744

1.44

3.27

2.1

2.3

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

824

7266

1.14

3.26

1.1

—

(3026389) Candida sp identified in Specimen by Organism specific culture

225

1759

1.28

3.24

1.4

1.3

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

843

7448

1.14

3.24

1.6

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

824

7275

1.14

3.20

4.1

3.8

u/l

227.1

231.6

0.45

783

6906

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

584

5034

1.17

3.17

1.1

u/ml

35.8

8.7

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

661

1.45

3.11

1.5

promille

1.4

1.3

0.32

495

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

2.40

3.11

7.7

10.2

mmol/l

4.5

5.0

0.40

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

750

6606

1.14

3.04

1.4

1.3

miu/ml

207.7

233.7

1.42

385

3406

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

189

1460

1.30

3.01

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

189

1460

1.30

3.01

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

398

3339

1.20

3.00

1.2

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

636

5543

1.15

3.00

1.7

1.6

—

(3041806) Other cells [#/volume] in Blood by Manual count

721

0.59

3.00

1.3

1.5

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

437

3700

1.19

2.98

2.5

1.9

g/l

0.2

1.14

408

3525

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

393

3297

1.20

2.97

1.2

1.1

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

849

7552

1.13

2.96

6.8

6.3

mmol/l

104.8

104.9

0.31

833

7411

(3013826) Glucose [Moles/volume] in Serum or Plasma

5284

50887

1.06

2.91

4.0

3.8

mmol/l

6.2

6.3

1.46

4796

45744

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

10022

98577

1.09

2.90

3.5

mmol/l

4.9

0.30

9581

94059

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

447

3805

1.18

2.87

2.5

1.9

g/l

1.1

1.2

2.17

420

3635

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

9596

94241

1.08

2.85

3.1

3.2

mmol/l

1.2

0.05

9107

89595

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

9972

98084

1.08

2.83

3.4

3.5

mmol/l

1.6

0.26

9503

93435

(3014765) Yersinia sp identified in Stool by Organism specific culture

395

3332

1.19

2.83

1.2

1.1

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

204

1609

1.27

2.79

2.6

2.5

—

(3052851) Hemolysis interference index of Serum or Plasma

297

2443

1.22

2.78

3.0

2.5

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

433

1.52

2.75

2.0

2.3

umol/l

131.9

171.3

0.64

207

(4010399)

690

6091

1.14

2.73

1.3

1.4

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

317

2631

1.21

2.72

2.2

1.9

g/l

1.4

0.52

273

2273

(3051611) Lipemic interference index of Serum or Plasma

103

739

1.39

2.71

3.3

2.7

—

(3028026) IgM [Mass/volume] in Serum or Plasma

649

5712

1.14

2.69

1.7

1.8

g/l

1.3

0.52

600

5289

(3002032) Base excess in Venous blood by calculation

584

5107

1.15

2.66

4.0

3.6

mmol/l

2.0

1.8

0.70

477

4142

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

208

1656

1.26

2.65

1.9

2.0

g/l

0.0

1.44

192

1521

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

460

3955

1.17

2.64

2.6

2.0

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

2.65

2.60

1.2

ml/s/173m2

8.8

1.3

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

246

2002

1.23

2.59

2.3

2.0

g/l

3.0

0.02

196

1582

(3022217) INR in Platelet poor plasma by Coagulation assay

783

6994

1.13

2.58

12.7

inr

1.1

0.08

114

1199

(3048929) Epstein Barr virus Ab [Presence] in Serum

489

4233

1.16

2.58

1.2

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

689

1.39

2.55

1.6

1.4

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

4517

43422

1.06

2.54

2.3

nmol/l

75.9

2089.2

0.50

4190

40715

(3004716) Salmonella sp identified in Stool by Organism specific culture

832

7467

1.12

2.54

1.5

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

109

800

1.36

2.53

1.1

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1334

12269

1.10

2.53

3.2

3.0

mmol/l

0.8

0.96

1247

11494

(3017732) Neutrophils [#/volume] in Blood

854

7679

1.12

2.52

2.4

2.3

e9/l

4.2

4.1

0.41

708

6478

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

9149

89821

1.07

2.48

3.9

3.8

—

(21494890) Protein electrophoresis panel - 24 hour Urine

444

1.49

2.48

2.0

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2501

23608

1.07

2.48

2.1

mg/l

2.7

0.54

2144

20428

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

151

1167

1.29

2.47

1.6

1.5

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

241

1969

1.23

2.46

3.9

2.9

mg/l

1.4

1.3

0.64

229

1846

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

221

1790

1.24

2.45

2.3

2.1

g/l

0.6

0.5

0.32

199

1591

(3021447) Carbon dioxide [Partial pressure] in Venous blood

585

5150

1.14

2.45

4.1

3.6

kpa

5.9

5.8

0.70

572

4984

(3004588) Protein electrophoresis panel - Serum or Plasma

421

3626

1.16

2.40

2.1

2.0

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

609

5386

1.14

2.38

1.3

u/ml

1.6

1.0

0.41

433

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2521

23836

1.07

2.38

1.7

mg/l

0.9

0.53

1860

17716

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

337

2855

1.18

2.36

9.1

8.8

mmol/l

24.2

24.1

0.08

315

2693

(3001122) Ferritin [Mass/volume] in Serum or Plasma

5994

58184

1.06

2.32

2.9

3.0

ug/l

71.8

68.3

1.06

5673

55419

(3019309) Folate [Moles/volume] in Red Blood Cells

1358

12551

1.09

2.32

1.7

nmol/l

1178.8

1186.5

0.12

1095

9920

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

891

8071

1.11

2.32

2.3

au/ml

18.8

22.4

0.72

652

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

434

3758

1.16

2.32

6.1

mmol/l

24.6

24.5

0.08

429

3729

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

386

3315

1.17

2.30

1.4

1.3

u/ml

12.1

8.6

0.40

542

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

380

3260

1.17

2.29

1.4

1.3

u/ml

15.6

5.5

1.16

344

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

251

2078

1.21

2.27

2.3

2.0

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

251

2078

1.21

2.27

2.3

2.0

g/l

3.6

3.7

0.02

189

1520

(3051651) Icteric interference index of Serum or Plasma

453

1.46

2.27

3.9

3.1

—

(3003327) Ova and parasites identified in Stool by Light microscopy

523

4597

1.14

2.27

1.7

1.8

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

251

2081

1.21

2.25

2.3

2.0

g/l

7.2

0.03

199

1612

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

629

0.63

2.23

1.1

1.2

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

140

1089

1.29

2.22

1.4

1.5

—

(3000494) Fungus identified in Specimen by Culture

1170

10766

1.09

2.22

1.5

1.4

—

(3000330) Specific gravity of Urine by Test strip

433

3768

1.15

2.18

2.9

2.8

—

(3003181) Sodium [Moles/volume] in Urine

117

892

1.31

2.16

1.6

1.4

mmol/l

57.2

66.8

1.84

697

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

200

1630

1.23

2.14

1.8

1.9

g/l

39.0

38.9

0.10

179

1445

(3034860) Kappa light chains.free [Mass/volume] in Serum

171

1371

1.25

2.13

3.2

3.1

mg/l

37.3

38.3

0.07

141

1099

(36660697) Celiac disease serology panel - Serum

1110

10213

1.09

2.12

1.2

—

(21494814) CD8 cells/100 lymphocytes in Specimen

364

1.48

2.06

2.4

2.0

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

185

1502

1.23

2.06

1.9

2.0

g/l

0.0

0.50

169

1375

(40768446) Kidney Pathology biopsy report

284

1.55

2.05

1.8

1.6

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

183

1486

1.23

2.04

1.9

2.0

g/l

0.0

0.00

168

1372

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

170

1370

1.24

2.03

3.2

3.1

mg/l

29.0

35.0

0.57

140

1100

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1173

10840

1.09

2.03

2.0

2.1

29.4

29.1

0.60

1141

10477

(3016502) Oxygen saturation in Arterial blood

622

5570

1.12

2.03

7.1

7.2

96.3

96.4

0.05

595

5339

(3032080) INR in Blood by Coagulation assay

2894

27616

1.06

2.02

5.0

5.1

inr

1.1

0.04

954

9290

(3016228) CD19 cells/100 cells in Blood

367

1.47

1.99

2.4

2.0

7.7

8.6

0.28

361

(3042733) HLA Ab [Presence] in Serum

231

1.60

1.99

4.5

5.2

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

113

869

1.30

1.99

1.5

1.4

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

156

1249

1.25

1.99

5.2

5.4

umol/l

383.0

376.1

0.23

140

1080

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

199

1638

1.22

1.96

6.5

5.0

iu/ml

787.8

840.8

0.06

192

(3023420) DNA double strand Ab [Units/volume] in Serum

174

1414

1.23

1.94

2.2

1.7

iu/ml

32.6

35.2

0.11

(3023368) Bacteria identified in Blood by Culture

1884

17761

1.07

1.94

3.9

3.6

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

3302

31663

1.06

1.94

1.7

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

4.54

1.93

1.0

1.1

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

588

5267

1.12

1.93

6.9

6.4

mmol/l

1.2

0.82

564

5089

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

117

910

1.29

1.90

1.2

1.3

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1294

12049

1.08

1.88

2.4

2.2

g/l

2.4

2.5

2.46

1179

11207

(3027801) Oxygen [Partial pressure] in Arterial blood

713

6465

1.11

1.88

6.7

kpa

13.4

13.7

0.63

675

6172

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

713

6467

1.11

1.87

6.8

6.7

kpa

5.1

5.0

0.62

678

6179

(3010375) cycloSPORINE [Mass/volume] in Blood

324

1.48

1.85

24.0

24.8

ug/l

112.9

112.5

0.01

262

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

116

905

1.28

1.85

1.2

1.3

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

818

7473

1.10

1.85

1.3

au/ml

30.6

39.6

0.84

303

(44816559) Phosphatidylethanol [Mass/volume] in Blood

248

2097

1.18

1.85

1.2

1.3

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

734

6673

1.10

1.84

3.3

3.6

ug/l

18.1

23.3

0.20

546

4799

(3041096) Erythrocytes [Presence] in Urine by Automated

3138

30091

1.05

1.83

2.9

2.8

—

(3003396) Base excess in Arterial blood by calculation

713

6474

1.11

1.83

6.7

mmol/l

0.9

0.8

0.12

536

4904

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.20

1.83

1.0

1.6

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

107

828

1.29

1.83

1.3

1.2

u/ml

74.3

53.6

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

341

2962

1.15

1.82

1.3

—

(3024928) Oxygen saturation in Venous blood

151

1219

1.24

1.82

4.2

3.5

—

(3024354) Oxygen [Partial pressure] in Venous blood

467

4150

1.13

1.78

3.3

3.0

kpa

4.5

4.7

0.92

453

4006

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

357

3120

1.15

1.76

2.2

2.5

g/l

3.7

3.6

0.79

334

2945

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

378

1.43

1.75

1.7

1.6

au/ml

172.9

136.7

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

2.43

1.74

1.2

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

273

2343

1.17

1.72

1.2

—

(3028433) Virus identified in Specimen by Culture

281

1.49

1.71

1.1

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

305

2644

1.15

1.69

2.4

2.1

mg/l

10.0

10.1

0.14

291

2489

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

227

1923

1.18

1.69

2.3

2.0

g/l

10.3

10.1

0.25

196

1653

(3009445) Proteinase 3 Ab [Units/volume] in Serum

380

3346

1.14

1.69

1.4

1.5

u/ml

6.4

9.5

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

337

2944

1.15

1.68

1.3

u/ml

46.5

39.7

0.35

314

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

106

830

1.28

1.68

1.3

u/ml

54.3

42.8

—

(3020779) Urea [Moles/volume] in Serum or Plasma

546

4916

1.11

1.67

9.2

7.0

mmol/l

7.9

7.2

1.77

522

4734

(3038026) Centromere Ab [Units/volume] in Serum

108

848

1.27

1.67

1.3

u/ml

21.0

59.5

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

117

928

1.26

1.67

3.4

1.6

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.09

1.64

1.0

1.6

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

588

5322

1.11

1.64

7.5

7.4

g/l

119.1

120.8

1.32

571

5117

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

161

1328

1.21

1.61

3.3

3.1

ratio

1.4

1.9

—

145

(3000570) Elastase.pancreatic [Mass/mass] in Stool

278

2404

1.16

1.61

1.3

1.4

ug/g

331.4

308.1

1.03

163

1228

(3024891) Influenza virus A+B Ag [Presence] in Specimen

348

3058

1.14

1.61

1.1

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

102

800

1.27

1.61

1.3

u/ml

16.6

3.9

0.79

(3001964) Herpes simplex virus Ag [Presence] in Specimen

311

1.45

1.59

1.2

1.3

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

755

6934

1.09

1.57

2.4

2.2

g/l

0.2

1.76

708

6548

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

457

4092

1.12

1.57

1.9

2.0

ug/l

6.3

5.5

0.18

407

3567

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

256

2206

1.16

1.57

1.3

1.2

u/ml

288.2

258.8

1.01

180

1491

(21494755) Public health laboratory ask at order entry panel

1531

16146

0.94

1.57

1.3

—

(3045424) Erythrocytes [Presence] in Urine

202

1709

1.18

1.55

1.4

1.5

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2440

23344

1.05

1.55

1.6

mmol/l

1.4

1.3

0.25

2123

20415

(3017354) Segmented neutrophils/100 leukocytes in Blood

629

1.30

1.54

3.2

2.5

57.0

56.2

0.11

398

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

271

2349

1.15

1.54

1.3

1.2

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.00

1.52

0.0

1.2

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

185

1.57

1.49

1.0

1.1

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

346

3059

1.13

1.48

8.4

8.6

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

243

2098

1.16

1.47

1.4

iu/ml

10.1

13.2

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

101

802

1.26

1.47

1.2

1.3

—

(3013293) Extractable nuclear Ab [Presence] in Serum

210

1.52

1.46

1.7

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

139

1144

1.21

1.46

1.1

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

148

1226

1.21

1.45

2.9

2.4

u/ml

635.9

13769.0

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

312

2745

1.14

1.45

1.5

1.7

titre

412.7

337.3

0.14

118

(3011648) Oxygen content in Venous blood

497

1.33

1.43

2.2

2.5

10.4

11.1

0.79

497

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

2.72

1.43

1.0

1.1

nmol/l

178.5

242.4

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

292

2561

1.14

1.43

1.4

1.3

u/ml

2.1

3.8

0.54

193

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

2.30

1.42

6.2

3.9

—

(3052592) Norovirus Ag [Presence] in Stool

125

1.68

1.42

1.2

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

732

6750

1.09

1.41

2.2

2.3

ml/min/173m2

75.2

76.8

0.49

269

2519

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

481

1.33

1.41

1.3

1.6

—

(1761868) Lipid panel - Serum or Plasma

4117

42217

0.96

1.41

2.2

—

(3010503) CD19 cells [#/volume] in Blood

561

1.30

1.38

3.2

2.5

e9/l

0.2

0.21

552

(3008898) HLA-B27 [Presence]

647

5942

1.09

1.38

1.1

—

(3009542) Hematocrit [Volume Fraction] of Blood

10132

100226

1.05

1.38

12.0

11.0

39.6

39.5

1.55

8412

82299

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

321

1.40

1.37

9.0

5.1

u/ml

51.0

1895.5

0.57

(3027456) Digoxin [Moles/volume] in Serum or Plasma

458

1.33

1.36

2.8

3.1

nmol/l

0.8

0.41

333

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.60

1.36

1.0

1.1

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

1.34

0.0

1.3

—

(3023183) Ammonium ion [Moles/volume] in Plasma

142

1185

1.20

1.32

3.3

3.0

umol/l

33.2

33.0

0.02

127

1025

(40768441) Liver Pathology biopsy report

698

1.26

1.32

1.6

1.3

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

125

1031

1.21

1.31

1.2

—

(3017166) Chili Pepper IgE Ab [Units/volume] in Serum

0.00

1.31

0.0

1.0

—

0.0

—

(3004809) Band form neutrophils/100 leukocytes in Blood

126

1041

1.21

1.30

2.9

2.6

1.2

1.4

0.42

811

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

125

1032

1.21

1.30

1.2

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

292

2582

1.13

1.29

1.2

1.3

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

125

1034

1.21

1.28

1.2

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

206

1779

1.16

1.28

1.2

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

292

1.40

1.28

3.1

4.1

mg/l

4122.2

3208.4

0.08

212

(3013139) Helicobacter pylori Ag [Presence] in Stool

844

7865

1.08

1.28

1.2

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

192

0.52

1.27

1.2

—

(3019225) pH of Specimen

790

7345

1.08

1.27

3.1

3.4

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

2.28

1.26

1.0

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

482

1.31

1.26

2.0

1.8

mg/l

8.8

9.6

0.48

390

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

132

1100

1.20

1.26

1.4

1.5

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

562

1.28

1.24

2.2

2.7

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

2.40

1.24

1.5

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

126

1048

1.20

1.23

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

126

1048

1.20

1.23

1.2

—

(3030313) Adrenal Ab [Titer] in Serum

187

1.50

1.22

1.1

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

214

2443

0.87

1.22

1.6

mmol/l

7.6

7.5

0.03

134

1500

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

126

1050

1.20

1.21

1.2

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1648

17196

0.95

1.20

2.0

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1244

11774

1.06

1.19

1.2

iu/ml

162.3

152.2

0.32

481

4715

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1138

10747

1.06

1.18

2.6

2.3

24.6

23.7

1.40

989

9312

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

145

1228

1.18

1.17

1.1

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

701

1.24

1.17

2.2

1.7

100.9

101.0

0.01

625

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

277

2460

1.13

1.17

1.3

1.2

u/ml

0.7

18.3

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

107

882

1.21

1.16

1.7

1.9

mg/l

23.3

23.5

0.01

246

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

1.15

0.0

8.8

—

(3021788) Differential panel - Synovial fluid

153

1307

1.17

1.13

1.5

1.6

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

355

3908

0.90

1.12

1.2

—

(3027945) Reticulocytes/100 erythrocytes in Blood

716

6671

1.08

1.12

2.4

2.5

1.7

0.04

643

5952

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

527

1.27

1.12

1.1

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

796

1.22

1.11

2.3

2.0

10.3

13.0

1.53

423

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

284

1.37

1.10

1.0

1.1

—

(3010838) Calcium [Moles/time] in 24 hour Urine

480

0.73

1.10

1.6

mmol/24h

4.6

5.8

—

(3022948) Iron [Moles/volume] in Serum or Plasma

1414

13471

1.05

1.09

2.4

2.2

umol/l

14.9

14.4

1.94

1306

12534

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

457

4187

1.09

1.4

pmol/l

81.2

97.8

0.65

451

4082

(40760888) Immunoglobulin light chains.free panel - Serum

122

1027

1.19

1.08

3.5

3.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1001

10554

0.94

1.07

1.6

1.7

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.68

1.06

1.0

1.1

umol/24h

1.6

1.5

0.13

(3037121) Protein [Mass/volume] in Urine

286

2565

1.12

1.05

3.2

2.8

g/l

0.2

0.3

1.53

109

1009

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

260

2320

1.12

1.04

1.3

1.4

—

(3002179) Metamyelocytes/100 leukocytes in Blood

736

6886

1.07

1.04

4.0

3.8

0.7

0.6

0.13

143

1207

(3003458) Phosphate [Moles/volume] in Serum or Plasma

947

8934

1.06

1.04

6.3

4.9

mmol/l

1.0

0.07

891

8402

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

794

1.21

1.04

1.0

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

262

1.37

1.04

2.3

1.9

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

358

3253

1.10

1.03

2.0

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

280

1.36

1.02

1.1

—

(4281824)

153

1321

1.16

1.01

1.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

742

1.21

1.01

2.2

2.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1876

18038

1.04

1.00

1.4

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1573

16345

0.95

0.99

1.5

—

(40768797) Stomach Pathology biopsy report

1362

13001

1.05

0.99

1.2

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

2.17

0.98

1.4

3.7

—

(3023520) Reticulocytes [#/volume] in Blood

493

4558

1.08

0.97

2.4

2.5

e9/l

70.4

72.4

0.50

369

3290

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1512

14479

1.05

0.97

2.5

2.4

ng/l

616.8

622.8

0.03

1233

11725

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

792

1.20

0.96

1.4

1.3

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

811

7637

1.06

0.96

2.6

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

100

1.60

0.95

1.6

2.2

u/field

0.6

0.9

0.43

100

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

203

1797

1.13

0.95

2.5

2.6

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

477

1.26

0.95

2.4

au/ml

258.4

154.6

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

281

2535

1.11

0.95

3.3

3.0

0.6

0.7

0.63

267

2428

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

224

1.38

0.95

1.0

1.1

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

976

9249

1.06

0.94

3.3

3.4

pmol/l

4.6

4.5

0.35

867

8370

(3019060) Gas panel - Arterial blood

384

3521

1.09

0.93

4.0

4.6

—

(3020961) Endomysium IgA Ab [Titer] in Serum

736

6918

1.07

0.93

1.1

titre

202.7

197.5

0.02

166

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

233

0.64

0.93

1.8

1.6

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

108

916

1.18

0.92

1.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

197

1746

1.13

0.92

1.4

—

(40760892) CBC W Ordered Manual Differential panel - Blood

2665

25858

1.04

0.91

4.0

3.9

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1022

9710

1.05

0.91

3.2

3.4

32.4

32.8

0.46

800

7287

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

323

2944

1.10

0.90

1.9

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

367

3365

1.09

0.90

3.3

3.2

g/l

128.7

129.6

0.37

361

3279

(4211845)

535

1.23

0.90

2.4

—

(40768806) Pleura Pathology biopsy report

348

0.72

0.90

1.3

1.5

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

176

1.42

0.89

1.5

1.4

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

140

1216

1.15

0.89

1.1

g/l

1.4

1.5

0.68

131

1105

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

2.07

0.89

1.2

1.1

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

493

4580

1.08

0.89

1.5

—

(3003694) ABO and Rh group [Type] in Blood

3661

35734

1.03

0.88

1.7

—

(3019174) dRVVT (LA screen)

135

1.48

0.88

1.1

1.2

—

(3005322) IgE [Units/volume] in Serum or Plasma

918

8708

1.06

0.87

1.2

1.3

u/ml

211.3

175.6

0.39

847

8087

(3039162) Centromere protein B Ab [Units/volume] in Serum

185

1640

1.13

0.87

1.4

1.3

u/ml

49.6

51.4

0.03

108

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

747

1.19

0.87

1.1

1.2

titre

20.0

97.1

—

(3011412) CD3 cells [#/volume] in Blood

116

996

1.16

0.86

2.8

2.3

e9/l

1.4

1.3

0.11

572

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

748

1.19

0.86

1.1

1.2

titre

338.8

182.9

0.66

144

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

801

0.82

0.85

6.2

6.5

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

405

1.26

0.84

1.1

1.2

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

227

2043

1.11

0.83

1.3

—

(3020650) Glucose [Presence] in Urine

326

1.29

0.83

1.2

1.5

—

(3025315) Body weight

1.75

0.83

5.1

3.6

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

614

1.20

0.82

1.3

1.5

e6/l

23901.9

50400.2

0.53

422

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

240

2170

1.11

0.81

1.3

u/ml

134.6

109.3

0.64

527

(3006462) Nitrate [Presence] in Urine

479

1.23

0.81

2.4

2.5

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

1.87

0.81

1.2

1.0

—

(3020630) Protein [Mass/volume] in Serum or Plasma

504

4706

1.07

0.81

2.4

2.3

g/l

67.0

67.2

0.27

459

4354

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

319

1.28

0.80

1.1

1.2

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

453

1.23

0.80

1.1

u/ml

1.7

2.0

0.08

251

(3017569) Oxygen content in Arterial blood

206

1.36

0.80

2.8

2.1

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

582

5465

1.07

0.80

3.7

3.4

ng/l

77.9

75.9

0.21

533

4855

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

189

1.37

0.79

1.1

1.2

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

430

0.77

0.79

2.5

2.1

ug/l

1.5

1.3

0.13

411

(3021440) Promyelocytes/100 leukocytes in Blood

762

7215

1.06

0.79

4.2

4.1

0.1

0.2

0.94

177

1531

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.79

0.0

1.0

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

254

2308

1.10

0.79

1.3

u/ml

19.3

18.8

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

444

4133

1.07

0.78

2.3

2.4

ng/l

141.6

108.7

0.89

391

3687

(3024471) HLA-A [Type]

250

1.32

0.78

1.0

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

187

0.64

0.78

1.1

1.3

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

1.66

0.78

1.5

1.3

nmol/l

294.7

519.4

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

0.00

0.78

0.0

1.3

—

(3009754) Celery IgE Ab [Units/volume] in Serum

0.00

0.78

0.0

1.0

—

0.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

527

1.21

0.78

1.1

101.8

99.9

0.18

228

(3044009) aPTT.lupus sensitive (LA screen)

139

1.44

0.78

1.1

1.2

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

0.52

0.78

1.2

1.5

—

14.4

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

726

0.82

0.78

14.4

16.9

nmol/l

1447.4

3828.8

0.82

694

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

693

0.82

0.77

11.7

12.0

nmol/l

834.5

845.3

0.06

670

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

504

4716

1.07

0.77

1.6

1.7

—

(3007463) Buprenorphine [Presence] in Urine

1.62

0.77

14.3

7.4

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

1.55

0.77

1.2

2.4

—

(3009508) Creatinine [Moles/volume] in Urine

2281

22144

1.03

0.77

3.4

3.1

mmol/l

7.4

8.1

0.47

1980

19134

(3042111) Morphology [Interpretation] in Bone marrow Narrative

813

1.17

0.76

1.6

1.7

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

348

0.74

0.76

1.1

1.2

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

234

1.32

0.76

2.5

2.4

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

630

1.19

0.75

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

114

991

1.15

0.75

1.2

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

548

1.20

0.75

1.1

119.0

116.6

0.19

488

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.60

0.74

1.8

1.5

—

(3017181) Myelocytes/100 leukocytes in Blood

789

7497

1.05

0.74

4.2

4.0

0.7

0.9

1.01

186

1643

(3034092) Cytoplasmic Ig cells/100 cells in Blood

160

0.62

0.74

5.6

5.3

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

577

1.19

0.73

1.1

1.2

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.84

0.73

1.1

—

(3026493) Urate [Moles/volume] in Serum or Plasma

2224

21603

1.03

0.73

2.2

2.0

umol/l

1795.6

2599.5

0.89

1991

19298

(3025159) Blasts/100 leukocytes in Blood

730

6925

1.06

0.73

4.2

4.1

0.1

0.2

0.21

149

1311

(4034850)

329

3041

1.08

0.72

7.6

7.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.58

0.71

1.4

1.2

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

1.92

0.70

1.0

1.3

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

784

1.16

0.69

1.3

1.2

u/l

28.6

30.8

0.06

689

(3050794) Legionella sp Ab [Presence] in Serum

1.55

0.69

1.0

1.2

—

(3008037) Lactate [Moles/volume] in Venous blood

1122

0.87

0.68

2.3

2.4

mmol/l

1.4

0.07

1096

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.53

0.68

1.7

1.8

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.52

0.68

2.0

2.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

186

1681

1.11

0.68

1.1

—

(3023419) Bacteria identified in Sputum by Culture

712

1.16

0.67

3.2

2.6

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

272

0.73

0.67

3.9

3.0

—

(3016018) Differential panel - Cerebral spinal fluid

134

1192

1.12

0.65

1.2

1.3

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

114

1004

1.13

0.65

1.4

1.3

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

351

3269

1.07

0.65

2.1

2.2

159.9

166.1

0.89

335

3078

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

312

1.25

0.65

4.0

2.9

—

(3013512) EKG study

2104

20469

1.03

0.64

2.8

—

(3004616) Nuclear Ab [Presence] in Serum

158

1421

1.11

0.64

1.4

—

(3008295) Osmolality of Serum or Plasma

725

1.16

0.64

1.5

1.7

mosm/kgh2o

279.9

281.4

0.24

580

(3002523) Influenza virus A Ag [Presence] in Specimen

281

2597

1.08

0.64

1.1

—

(3000475) Leukocytes [#/volume] in Synovial fluid

181

1640

1.10

0.64

1.7

e6/l

6506.3

8226.9

0.75

133

1217

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

394

1.22

0.64

1.5

1.6

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

987

0.87

0.64

1.2

u/ml

0.1

0.9

2.33

371

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

125

1398

0.89

0.63

4.2

4.3

u/ml

110.9

106.2

0.03

446

(3022689) Creatine [Moles/volume] in Urine

207

1.30

0.62

1.6

1.5

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

566

0.83

0.62

1.9

2.0

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

544

0.82

0.62

1.1

1.2

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

112

990

1.13

0.62

1.0

—

(3038515) Glucose [Moles/volume] in Venous blood

1037

0.87

0.62

2.4

2.5

mmol/l

6.8

7.1

0.85

1016

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

663

1.16

0.61

1.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

390

3656

1.07

0.61

2.3

2.1

iu/l

36.0

10.5

0.38

173

1525

(3021162) Amylase [Enzymatic activity/volume] in Specimen

105

0.57

0.61

3.2

3.1

u/l

589.0

3189.2

—

(3003740) Influenza virus B Ag [Presence] in Specimen

280

2595

1.08

0.61

1.1

—

(3024932) HLA-DR beta [Type]

244

1.27

0.60

1.2

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

228

2097

1.09

0.60

1.6

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

159

1438

1.10

0.59

3.1

3.7

u/ml

0.4

0.47

801

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

480

1.19

0.59

3.9

4.0

—

(3020891) Body temperature

242

2232

1.08

0.59

3.8

4.4

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

518

1.18

0.58

3.0

2.9

mg/l

9.0

8.0

0.35

405

(3028626) Oxygen [Partial pressure] in Capillary blood

143

1288

1.11

0.58

2.9

2.4

kpa

9.1

8.8

0.55

132

1207

(3047189) Immunofixation for 24 hour Urine

192

1.30

0.58

1.8

—

(3029612) Listeria sp Ab [Titer] in Serum

1.51

0.58

1.8

1.4

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

140

1.35

0.57

1.2

1.1

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

449

4240

1.06

0.57

2.2

2.1

u/l

38.6

39.6

0.57

422

3949

(3044941) Cell count panel - Synovial fluid

120

1072

1.12

0.57

1.4

—

(4268621)

158

1433

1.10

0.57

2.2

2.3

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

538

1.17

0.57

1.1

103.4

96.3

1.46

233

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

101

893

1.13

0.57

1.5

1.4

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

318

1.22

0.57

1.5

1.4

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

194

1777

1.09

0.57

1.1

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

689

0.85

0.57

1.0

1.1

91.9

92.4

0.04

558

(3019977) pH of Arterial blood

291

1.24

0.57

2.5

2.8

7.4

0.25

(3036071) Salmonella sp Ab [Titer] in Serum

418

0.81

0.56

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

166

1814

0.91

0.56

3.4

3.2

mg/l

25.1

23.0

0.21

1095

(3001893) Eosinophils/100 leukocytes in Pleural fluid

0.57

0.56

1.0

1.4

3.2

3.8

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

115

1.39

0.56

1.4

1.1

—

(4062490)

127

1141

1.11

0.55

1.3

1.4

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

251

0.75

0.55

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

820

1.13

0.55

1.1

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

124

1.37

0.55

1.5

1.2

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

140

1540

0.91

0.54

3.7

2.9

nmol/l

0.9

0.12

121

1304

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

284

0.77

0.54

1.0

1.1

u/ml

0.1

0.9

1.49

201

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

559

1.16

0.54

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

671

1.15

0.54

1.1

—

(3034988) Calcium [Moles/volume] in Capillary blood

124

0.64

0.54

2.5

2.0

mmol/l

1.2

—

115

(4094501)

207

1907

1.08

0.54

1.1

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

397

4190

0.94

0.54

1.1

u/ml

3.4

4.9

0.81

671

(40763590) HLA-DQ beta [Type]

1.58

0.54

1.0

—

(40760410) HLA-B [Type] by High resolution

1.58

0.54

1.0

—

(40760409) HLA-A [Type] by High resolution

1.58

0.54

1.0

—

(46236302) HLA-C [Type] by High resolution typing

1.58

0.54

1.0

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

147

0.68

0.54

1.0

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

111

992

1.12

0.53

1.9

2.0

u/ml

177.8

1495.7

0.63

100

847

(3047352) Trisomy 18 risk [Likelihood] in Fetus

703

7309

0.96

0.53

1.4

—

(3013862) HLA-DP [Type]

1.54

0.53

1.0

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

224

2407

0.93

0.52

1.1

u/ml

2.5

2.8

0.25

129

1320

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

553

1.16

0.51

1.5

1.6

—

(1616796) Gas panel - Central venous blood

141

1544

0.91

0.51

3.7

2.7

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

1.50

0.51

1.0

1.4

83.7

68.9

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

336

0.80

0.51

1.0

1.1

—

(3005033) Fetal Nuchal fold Thickness US

703

7298

0.96

0.51

1.4

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

247

0.77

0.50

1.1

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

247

0.77

0.50

1.2

1.4

nmol/l

206.1

107.9

1.05

194

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

564

1.15

0.50

1.7

1.6

u/l

10.0

5.1

0.55

264

(3044242) Glucose [Moles/volume] in Arterial blood

242

1.24

0.50

2.4

2.0

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

144

1.32

0.50

1.2

1.1

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

375

3543

1.06

0.49

6.0

6.3

mmol/l

24.3

24.4

0.10

352

3271

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

306

1.21

0.49

1.1

70.1

74.2

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

306

1.21

0.49

1.1

88.6

89.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

162

1.29

0.49

1.4

1.5

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

500

1.16

0.49

1.2

u/l

27.7

17.2

0.36

435

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

454

1.17

0.48

1.2

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

189

1.27

0.48

1.0

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

107

0.65

0.48

1.3

1.1

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

189

0.74

0.48

1.0

1.1

—

(40758292) HTLV I+II Ab panel - Serum

136

1.32

0.48

1.2

1.3

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

160

1468

1.09

0.48

2.8

2.6

mmol/l

24.8

24.3

0.95

140

1298

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

185

1992

0.93

0.47

1.1

116.5

120.5

1.05

167

1815

(3007566) Smooth muscle Ab [Titer] in Serum

299

2811

1.06

0.47

1.3

titre

107.6

145.6

0.36

272

(3043238) Trisomy 21 risk [Likelihood] in Fetus

723

7486

0.96

0.47

1.5

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

119

1.34

0.47

1.3

2.2

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

288

0.80

0.47

2.7

1.8

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

1.46

0.46

2.1

2.0

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

512

1.15

0.46

1.3

1.2

u/l

85.3

80.9

0.15

457

(3035933) Granulocytes/100 leukocytes in Blood

382

1.18

0.46

1.5

1.8

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

374

3543

1.06

0.46

1.2

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

672

1.13

0.46

1.1

u/ml

8.5

11.1

0.25

114

(40768443) Skin Pathology biopsy report

382

4010

0.95

0.46

1.2

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

1.43

0.45

1.0

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

219

2338

0.93

0.45

1.3

1.5

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

118

0.68

0.45

1.5

1.7

—

(3017509) Phencyclidine [Presence] in Urine

182

1.26

0.45

1.7

—

(3002619) Bacteria identified in Specimen by Culture

182

1.26

0.45

1.5

1.1

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

125

1138

1.10

0.45

1.3

1.4

g/l

2.7

3.0

1.66

808

(3017446) Testosterone [Moles/volume] in Serum or Plasma

173

1863

0.93

0.45

1.4

1.3

nmol/l

1.4

0.00

149

1541

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

125

1139

1.10

0.45

1.4

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

125

1139

1.10

0.45

1.3

1.4

g/l

0.4

0.22

814

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

1.40

0.45

1.0

1.3

ug/g

256.7

143.3

—

(3006653) Thiamine [Moles/volume] in Blood

534

0.86

0.44

1.3

1.5

nmol/l

123.9

131.7

0.71

534

(3027135) IgG subclass 1 [Mass/volume] in Serum

125

1140

1.10

0.44

1.3

1.4

g/l

7.1

6.6

0.63

811

(3005988) Vibrio sp identified in Specimen by Organism specific culture

125

1140

1.10

0.44

1.4

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

291

2742

1.06

0.44

1.2

1.3

mg/l

523.3

442.9

0.62

278

2624

(4306422)

196

2097

0.93

0.44

1.2

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

178

1910

0.93

0.43

2.3

2.0

ug/l

3.5

1.9

0.61

153

1700

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

311

1.19

0.43

1.5

1.4

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

122

1330

0.91

0.43

2.7

2.5

ug/min

67.5

75.5

0.12

843

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

525

1.14

0.43

1.2

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

185

0.75

0.43

1.0

1.1

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

105

951

1.10

0.43

1.0

u/ml

0.5

0.3

—

128

(3036180) Methadone [Presence] in Urine

1.61

0.43

3.4

2.1

—

(3007916) DNA double strand Ab [Titer] in Serum

148

1.28

0.42

1.0

1.4

—

134.6

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.41

0.42

1.4

1.9

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.43

0.42

1.0

1.1

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

201

1876

1.07

0.42

2.2

2.1

ug/l

492.3

420.2

0.13

176

1651

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

228

0.79

0.41

1.1

—

(3017704) Immunofixation for Urine

230

1.22

0.41

2.6

1.5

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

604

0.88

0.41

1.9

1.6

nmol/l

1.6

11.6

0.59

492

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

216

2296

0.94

0.41

1.5

mmol/l

7.0

6.6

0.82

155

1655

(3020356) Listeria sp identified in Specimen by Organism specific culture

172

0.75

0.41

1.2

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

229

2149

1.06

0.41

1.2

—

(3020874) Milk IgE Ab [Units/volume] in Serum

114

1041

1.09

0.40

1.0

1.1

u/ml

0.3

1.3

1.53

269

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1754

17855

0.98

0.40

1.6

pmol/l

56040046.1

36097804.0

0.61

1515

15569

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.47

0.40

1.0

1.9

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

126

1157

1.09

0.40

1.4

—

(3015183) Erythrocyte sedimentation rate

832

1.10

0.40

1.2

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

258

2433

1.06

0.40

1.2

1.3

e6/l

87.6

20.6

0.73

198

1878

(3025468) Yersinia sp identified in Specimen by Organism specific culture

124

1139

1.09

0.39

1.4

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

102

0.68

0.39

1.0

1.1

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.31

0.39

1.4

1.6

umol/24h

322.3

305.7

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

104

0.67

0.39

1.0

—

(3012516) Albumin [Mass/volume] in Urine

1781

18117

0.98

0.39

3.5

3.2

mg/l

472.1

491.6

0.06

1101

10893

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.43

0.39

1.2

1.1

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.43

0.39

1.2

1.0

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

241

1.20

0.39

1.3

1.2

nmol/l

0.5

0.4

0.36

165

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.39

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.39

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.39

0.0

2.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.39

0.0

2.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.39

0.0

1.9

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.39

0.0

1.0

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

345

0.84

0.39

1.4

e6/l

24946.0

53834.6

0.58

193

(3030981) Hyaline casts [#/volume] in Urine by Automated count

415

3967

1.05

0.38

2.5

2.4

e6/l

0.3

0.02

394

3788

(44813793)

110

1006

1.09

0.38

1.1

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

258

2436

1.06

0.38

1.2

1.3

e6/l

15369.1

1400.1

0.47

204

1975

(3020491) Glucose [Moles/volume] in Blood

815

1.10

0.38

1.4

1.6

mmol/l

5.8

5.9

0.19

654

(3038177) Helicobacter pylori Ab [Presence] in Serum

249

2349

1.06

0.38

1.2

1.1

—

(3023410) Appearance of Cerebral spinal fluid

126

1160

1.08

0.38

1.2

1.4

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

137

1266

1.08

0.38

1.5

1.4

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.39

0.38

1.0

—

(3047181) Lactate [Moles/volume] in Blood

229

2156

1.06

0.38

4.3

4.8

mmol/l

1.2

0.23

206

1898

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

139

1495

0.93

0.38

1.4

1.5

mmol/l

9.2

10.9

1.48

187

(3004775) Volume in Urine collected for unspecified duration

419

0.86

0.38

2.5

2.3

575.6

605.4

0.26

336

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

883

1.10

0.38

1.3

1.5

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

428

1.14

0.38

1.2

1.3

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

608

0.89

0.36

1.7

1.8

u/field

4.2

2.2

0.74

314

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

207

1.21

0.35

4.2

4.4

—

(4024509)

772

1.10

0.35

1.4

1.5

—

(3050129) First trimester maternal screen panel - Serum or Plasma

1065

10885

0.97

0.35

1.4

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

1.43

0.35

1.2

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

211

2229

0.94

0.35

3.3

2.8

mmol/l

24.7

0.09

201

2078

(40762365) Oxygen content in Arterial blood by calculation

0.62

0.35

5.2

1.9

ml/dl

14.4

14.7

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

122

0.74

0.35

1.2

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

124

0.72

0.35

1.0

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

125

1157

1.08

0.35

1.4

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

731

0.90

0.35

1.3

1.2

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

126

0.71

0.34

1.0

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

869

1.09

0.34

1.5

1.4

—

(4015189)

117

1.28

0.34

2.3

—

(3045142) Bone marrow Pathology biopsy report

602

1.11

0.34

1.3

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

126

1.27

0.34

1.6

2.0

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

413

1.14

0.34

2.1

2.0

ug/l

53.9

20.1

0.64

406

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

150

1600

0.93

0.34

1.4

1.2

—

(3043409) Potassium [Moles/volume] in Arterial blood

179

1680

1.06

0.34

3.5

4.0

mmol/l

3.7

3.8

0.10

169

1577

(3039000) Anion gap in Blood

146

1361

1.07

0.34

5.2

6.2

mmol/l

11.1

0.01

132

1223

(3018572) Chloride [Moles/volume] in Blood

146

1362

1.07

0.33

5.2

6.2

mmol/l

105.9

105.6

0.35

132

1224

(3009871) Measles virus Ab [Titer] in Serum

456

0.87

0.33

1.6

1.7

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

910

1.09

0.33

1.1

1.2

—

(3035637) Corticotropin [Mass/volume] in Plasma

116

1247

0.93

0.33

1.7

1.6

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

302

1.16

0.33

3.6

2.7

ng/l

147.2

85.5

0.45

153

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

0.69

0.33

1.0

—

(3021901) Oxygen saturation in Capillary blood

113

1046

1.08

0.32

3.0

2.4

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

171

1607

1.06

0.32

1.3

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

284

0.84

0.32

2.6

1.8

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

284

0.84

0.32

2.6

1.8

—

(1002224) Polysomnography panel

497

5128

0.97

0.32

1.1

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

127

1182

1.07

0.32

1.4

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

137

1279

1.07

0.31

1.1

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

103

951

1.08

0.31

1.2

u/l

56.7

58.1

0.12

637

(3020393) Adenovirus Ag [Presence] in Stool

1.32

0.31

1.1

1.0

—

(3029075) Extractable nuclear Ab panel - Serum

360

1.14

0.31

1.0

1.1

—

(40761536) Microorganisms panel - Urine sediment

969

9450

1.03

0.31

3.6

3.3

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

126

1346

0.93

0.31

1.1

—

68.3

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

153

1623

0.94

0.31

1.1

iu/ml

104.1

6410.6

0.63

420

(40757373) Influenza virus identified in Isolate

142

0.77

0.31

1.1

1.4

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.72

0.30

1.0

1.1

—

(3022475) Manganese [Moles/volume] in Blood

0.71

0.30

1.0

1.2

—

(3005570) Glucose [Moles/volume] in Urine

896

1.08

0.30

1.7

2.0

—

0.8

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

108

1158

0.93

0.30

1.4

1.3

umol/l

6.1

5.5

1.18

101

1066

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

185

0.81

0.30

1.7

1.3

29.2

44.2

—

120

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

130

0.77

0.29

2.1

1.6

mg/l

1.0

2.0

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

130

0.77

0.29

2.1

1.6

mg/l

2.8

2.4

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

228

2169

1.05

0.29

1.1

—

(40768793) Breast Pathology biopsy report

326

3382

0.96

0.29

1.2

1.3

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

238

0.84

0.29

1.1

u/ml

0.0

0.51

146

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

100

927

1.08

0.29

1.0

1.1

iu/ml

7.3

8.8

0.41

284

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

325

1.14

0.28

1.0

1.1

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

325

1.14

0.28

1.1

1.2

106.5

106.4

0.01

303

(3006184) Hemoglobin [Mass/volume] in Capillary blood

166

1568

1.06

0.28

2.3

1.9

g/l

131.1

130.7

0.07

119

1175

(3005082) Progesterone [Moles/volume] in Serum or Plasma

171

1800

0.95

0.28

1.3

1.4

nmol/l

29.5

31.8

0.60

162

1649

(3033923) Metanephrine [Moles/time] in 24 hour Urine

176

1.19

0.28

1.0

1.1

umol/24h

0.6

0.14

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.29

0.28

1.1

1.0

u/l

21.0

11.4

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

127

1348

0.94

0.27

1.1

—

21.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.27

0.27

1.2

1.1

—

(44806420)

1.29

0.27

2.6

2.1

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

406

0.88

0.27

1.1

u/ml

58.2

55.7

0.08

398

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

150

0.80

0.27

1.2

1.1

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

300

0.86

0.27

1.0

ng/l

32.4

41.8

1.12

222

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

120

0.75

0.27

1.2

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

257

2459

1.04

0.27

1.8

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

510

0.90

0.27

1.2

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

541

0.90

0.27

1.0

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

122

1.23

0.26

1.5

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

845

1.08

0.26

1.1

1.2

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

674

0.92

0.25

1.4

umol/l

64.8

64.9

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

591

0.91

0.25

1.0

1.1

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

750

1.08

0.25

3.1

2.4

e9/l

0.2

0.05

628

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

371

0.89

0.25

2.2

1.7

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

128

1207

1.06

0.24

1.4

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

607

1.09

0.24

3.3

2.7

u/ml

1078.0

847.7

0.25

602

(3051593) INR in Capillary blood by Coagulation assay

180

0.83

0.24

2.7

6.3

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

412

0.90

0.24

1.2

1.4

u/ml

13.0

19.0

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

349

1.12

0.24

1.2

22.3

18.5

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

370

0.89

0.24

2.2

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

370

0.89

0.24

2.2

1.7

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

370

0.89

0.24

2.2

1.7

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

762

1.07

0.24

3.0

2.4

e6/l

569.6

516.6

0.61

624

(3043410) Blood group antigens tested for on Red Blood Cells

264

1.13

0.24

1.1

1.5

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

133

1.20

0.23

1.2

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

799

7813

1.02

0.23

1.5

1.6

mu/l

287.5

311.6

1.10

722

6921

(4146454)

515

0.91

0.23

2.9

—

(4027681)

105

986

1.06

0.23

1.3

1.2

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

902

8834

1.02

0.23

1.4

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

696

1.08

0.23

3.7

2.9

—

(4212803)

1.28

0.23

1.0

—

(3006598) pH of Arterial cord blood

1.28

0.23

1.2

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1873

18917

0.99

0.22

4.0

3.9

mg/mmol

12.0

9.7

0.72

1147

11670

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

370

1.11

0.22

1.0

1.1

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

562

1.08

0.22

3.1

2.6

nmol/l

118.7

104.2

0.15

550

(3038071) Oxygen [Partial pressure] in Mixed venous blood

0.76

0.22

14.3

12.4

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.25

0.22

1.0

1.1

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

294

0.88

0.22

1.0

ng/l

267.6

336.9

1.21

223

(3008536) Aspergillus sp Ab [Presence] in Serum

125

1.20

0.22

2.6

2.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

863

0.94

0.21

1.1

u/l

0.9

1.0

2.88

351

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

903

8853

1.02

0.21

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

898

8804

1.02

0.21

1.4

—

(3036005) Urine sediment comments by Light microscopy Narrative

0.00

0.21

0.0

1.3

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.21

0.0

2.4

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

0.21

0.0

4.2

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

1.19

0.21

1.0

1.1

—

(3001556) Androgen free Index in Serum or Plasma

209

0.86

0.21

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

708

0.93

0.21

1.1

miu/ml

1446.1

1497.5

0.14

708

(3019420) Tryptase [Mass/volume] in Serum or Plasma

749

0.93

0.21

1.3

1.4

ug/l

5.1

7.1

1.91

672

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

119

1251

0.95

0.21

1.1

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.21

0.0

1.1

—

(3020618) Glucose [Moles/volume] in Synovial fluid

0.00

0.21

0.0

1.0

—

6.8

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

424

4343

0.97

0.21

1.3

ug/l

3.6

3.1

0.28

391

3991

(3034891) Synovial lining cells/100 cells in Synovial fluid

366

0.90

0.21

1.7

1.5

3.8

4.9

0.35

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

134

0.82

0.21

2.1

1.6

mg/l

1.5

2.3

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

134

0.82

0.21

1.0

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

166

0.84

0.21

2.8

2.6

—

(3027020) Pear IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.4

—

(3035082) Kappa light chains [Mass/volume] in Urine

0.00

0.21

0.0

1.1

—

0.1

—

(3007542) Rye IgE Ab [Units/volume] in Serum

1.22

0.21

1.0

1.1

u/ml

0.1

22.5

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

192

1842

1.04

0.20

3.1

2.4

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

407

3958

1.03

0.20

1.4

—

(3000060) B lymphocytes [#/volume] in Blood

354

1.10

0.20

1.9

2.1

e6/l

253.2

181.3

0.38

187

(3044290) Cell count panel - Cerebral spinal fluid

238

2295

1.04

0.20

1.2

1.3

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

114

0.79

0.20

2.4

1.9

mmol/l

1.2

—

107

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

115

0.78

0.20

1.0

u/ml

0.2

0.5

—

104

(3014271) Vancomycin [Susceptibility]

165

0.85

0.19

1.7

2.6

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

128

1218

1.05

0.19

1.1

1.2

mg/l

33.0

36.8

0.65

100

1022

(3036782) Glucose [Moles/volume] in Pleural fluid

384

1.09

0.19

1.2

mmol/l

6.1

0.01

357

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

902

8859

1.02

0.19

1.4

—

(3005011) Chlamydia sp Ab [Titer] in Serum

196

0.87

0.19

1.5

1.6

—

(3010937) Rubella virus Ab [Presence] in Serum

143

0.84

0.19

1.3

1.1

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

311

0.90

0.19

3.0

2.9

umol/l

30.2

27.8

0.96

230

(3009343) pH of Capillary blood

352

3604

0.97

0.18

3.2

2.8

7.4

0.42

511

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

121

0.82

0.18

3.0

2.2

mmol/l

5.4

6.5

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

217

2238

0.97

0.18

1.1

au/ml

9.4

10.3

0.08

168

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

630

0.93

0.18

1.5

1.4

u/l

4.4

5.2

1.99

542

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1045

10283

1.02

0.18

2.0

nmol/l

382.9

376.0

0.55

972

9484

(3009677) Dengue virus Ab [Presence] in Serum

1.18

0.18

1.1

—

(3003338) MCHC [Mass/volume]

9400

93591

1.01

0.17

14.0

12.9

g/l

332.2

331.8

4.55

9341

92938

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.15

0.17

1.0

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

485

0.93

0.17

1.1

u/l

77.5

74.8

0.12

402

(3034274) Bile acid [Moles/volume] in Serum --fasting

364

3545

1.03

0.17

2.0

2.2

umol/l

4.3

5.0

1.42

265

2532

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

953

9376

1.02

0.17

1.5

—

(3000034) Microalbumin [Mass/volume] in Urine

629

1.06

0.17

2.8

2.7

mg/l

177.8

55.6

0.62

426

(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid

0.76

0.17

1.2

mg/l

0.0

—

(3045716) Anion gap in Serum or Plasma

262

1.10

0.16

6.0

2.5

mmol/l

9.7

9.3

0.16

195

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

246

0.89

0.16

1.1

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

291

1.10

0.16

2.1

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

354

3452

1.02

0.16

1.9

2.0

94.2

95.6

0.53

324

3143

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

245

0.90

0.16

1.1

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

466

4561

1.02

0.15

1.2

u/l

11.6

12.1

0.35

395

3805

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

182

0.88

0.15

1.1

1.3

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

162

1673

0.97

0.15

1.6

1.5

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

389

0.92

0.15

2.9

2.5

umol/l

52.3

49.5

0.26

331

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

341

3480

0.98

0.15

3.2

2.7

mmol/l

1.6

1.3

0.76

242

2441

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

296

0.91

0.15

1.0

ng/l

721.5

787.3

0.30

218

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

341

1.08

0.15

1.5

1.4

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

370

1.08

0.15

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

292

2844

1.03

0.15

1.1

u/ml

1.3

0.9

0.33

108

1149

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

102

1.17

0.14

1.0

1.2

—

1.1

—

(3022313) Gas panel - Capillary blood

240

2459

0.97

0.14

3.2

2.9

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

799

1.05

0.14

1.8

1.5

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

121

1.15

0.14

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

104

995

1.04

0.14

1.3

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

692

1.05

0.14

1.2

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

741

1.05

0.14

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

420

1.07

0.14

1.1

—

(3036048) Francisella tularensis Ab [Titer] in Serum

222

0.90

0.14

1.1

—

210.9

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

309

3016

1.02

0.14

1.1

u/ml

5.3

4.8

0.23

145

1536

(3027315) Oxygen [Partial pressure] in Blood

153

1577

0.97

0.14

3.3

3.0

kpa

9.2

9.0

0.47

148

1550

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

198

1.11

0.14

1.0

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

211

2049

1.03

0.14

1.1

1.0

u/ml

0.2

0.3

0.54

396

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

655

6442

1.02

0.14

3.6

3.1

mmol/l

1.2

1.71

569

5654

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

111

1151

0.96

0.13

1.5

1.6

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

227

1.10

0.13

1.6

1.4

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

158

1627

0.97

0.13

1.7

1.5

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

389

3956

0.98

0.13

2.3

2.2

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

335

0.92

0.13

1.1

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

103

1.16

0.13

2.5

7.0

—

(3024869) Neuronal Ab [Presence] in Serum

117

0.85

0.13

1.0

1.1

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

209

2141

0.97

0.13

3.2

3.7

u/ml

33.3

28.2

0.33

196

2058

(3044927) Protein electrophoresis panel - Urine

431

1.07

0.13

1.2

1.1

—

(3035880) pH of Pleural fluid

170

1.12

0.13

1.1

1.2

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

109

1129

0.96

0.13

3.2

3.4

u/ml

226.8

466.2

0.46

101

1031

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

106

0.85

0.13

1.0

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

107

1028

1.04

0.13

1.1

1.0

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1348

13330

1.01

0.13

1.5

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

451

1.06

0.13

1.2

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

297

2902

1.02

0.12

1.1

u/ml

1.3

1.9

0.58

705

(40768795) Lymph node Pathology biopsy report

852

1.04

0.12

1.1

1.2

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

783

0.96

0.12

1.1

1.2

u/ml

28.5

15.2

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

179

0.89

0.12

1.0

1.2

mg/l

0.9

93.7

—

132

(3037556) Urate [Mass/volume] in Serum or Plasma

179

0.89

0.12

1.1

1.2

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

559

1.05

0.12

1.1

1.2

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

119

1228

0.97

0.12

1.2

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

345

1.07

0.12

1.1

1.0

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

123

1.14

0.12

6.1

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

302

0.92

0.12

2.8

2.5

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

384

3897

0.98

0.11

1.5

1.4

nmol/l

0.5

0.04

310

3121

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

123

1189

1.03

0.11

1.0

1.1

mg/l

193.7

205.6

0.71

104

1046

(3010421) pH of Blood

188

1831

1.02

0.11

3.1

2.9

7.4

0.07

149

1537

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

102

1053

0.97

0.11

1.2

1.1

—

(40765096) Chromosome analysis panel by Banding

153

1.11

0.10

1.1

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

562

1.05

0.10

1.2

g/l

0.3

0.90

454

(3004451) EKG impression Narrative

211

1.09

0.10

1.3

1.2

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

565

5709

0.99

0.10

1.7

1.6

mg/l

2.9

3.4

1.24

383

3909

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

435

1.06

0.10

1.2

—

(3044007) Cell count panel - Peritoneal fluid

156

0.90

0.10

3.1

2.0

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

377

1.06

0.10

1.3

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

534

0.95

0.10

1.1

u/ml

13.9

8.8

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

248

2428

1.02

0.10

1.2

mmol/l

3.5

3.6

1.13

239

2268

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

270

1.07

0.10

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

270

1.07

0.10

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

270

1.07

0.10

1.1

—

(3049717) Cytology report of Urine Cyto stain

148

1440

1.03

0.10

1.9

2.0

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

574

0.96

0.10

1.5

1.4

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

238

2330

1.02

0.09

4.5

1.8

1.7

0.48

222

2172

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

299

0.93

0.09

2.0

1.6

ug/l

7.7

8.5

0.67

299

(3014599) Egg white IgE Ab [Units/volume] in Serum

107

1036

1.03

0.09

1.0

u/ml

0.9

2.0

0.51

229

(3013290) Carbon dioxide [Partial pressure] in Blood

153

1564

0.98

0.09

3.3

2.9

kpa

4.9

5.0

0.91

148

1537

(3012501) Base excess in Blood by calculation

153

1564

0.98

0.09

3.3

2.9

mmol/l

1.9

2.3

1.09

951

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

309

0.94

0.09

1.1

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

186

0.91

0.09

1.4

1.2

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

1.06

0.09

2.0

1.3

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

1.06

0.09

1.0

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

221

2163

1.02

0.09

1.3

1.2

u/ml

2.8

3.0

0.09

694

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

907

0.97

0.09

1.3

—

(3034426) Prothrombin time (PT)

428

1.05

0.09

1.1

1.2

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.11

0.09

4.2

4.5

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

134

1370

0.98

0.09

1.2

nmol/l

0.5

1.7

0.75

129

1330

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.03

0.08

1.2

1.0

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

480

0.96

0.08

1.1

u/l

20.5

17.1

0.26

386

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

0.83

0.08

1.0

1.3

—

23.4

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

123

0.89

0.08

1.2

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.78

0.08

1.0

—

(3011325) HIV 1+2 Ab [Presence] in Serum

0.78

0.08

1.0

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.09

0.08

2.9

3.0

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.09

0.08

1.0

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

206

2020

1.02

0.08

1.2

1.1

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

942

9332

1.01

0.08

1.3

—

(3018001) Oat IgE Ab [Units/volume] in Serum

127

1.10

0.07

1.0

u/ml

0.1

1.5

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

352

1.05

0.07

1.5

1.2

—

(3037756) Immunofixation for Serum or Plasma

904

1.03

0.07

2.2

1.7

—

(3032057) Clostridioides difficile [Presence] in Stool

137

1.09

0.07

1.7

1.9

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

0.87

0.07

1.1

1.3

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.86

0.07

1.0

1.1

—

(3051101) Glucose [Moles/volume] in Cord blood

0.85

0.07

1.9

4.5

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

143

1399

1.02

0.07

1.2

1.1

93.3

0.00

134

1319

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.02

0.07

1.0

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

244

0.94

0.06

1.0

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

206

2025

1.02

0.06

1.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

101

0.89

0.06

1.3

1.6

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

174

1709

1.02

0.06

1.4

1.5

g/l

0.5

0.6

0.96

124

1302

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

532

1.03

0.05

1.3

1.2

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

362

3646

0.99

0.05

3.2

2.8

kpa

5.2

5.1

0.87

337

3395

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

151

0.93

0.05

2.8

1.7

nmol/l

6.7

382932.7

—

123

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

535

0.97

0.05

1.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

385

1.04

0.05

1.3

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

234

2309

1.01

0.05

4.6

0.9

2.40

221

2157

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

100

979

1.02

0.05

1.1

ratio

1.1

0.02

365

(3014133) Dog dander IgE Ab [Units/volume] in Serum

252

2541

0.99

0.05

1.1

u/ml

3.0

4.8

0.74

954

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

115

1167

0.98

0.05

1.6

1.4

pmol/l

358.7

388.0

0.24

927

(3023430) Cat dander IgE Ab [Units/volume] in Serum

238

2400

0.99

0.04

1.1

u/ml

3.7

4.7

0.54

981

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

584

0.97

0.04

1.9

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

584

0.97

0.04

1.9

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

584

0.97

0.04

1.9

1.5

—

(3040151) Glucose [Moles/volume] in Capillary blood

772

1.02

0.04

3.4

3.6

mmol/l

5.9

7.0

3.23

634

(3023487) Leukocytes [#/volume] in Peritoneal fluid

189

1.06

0.04

2.4

2.1

e6/l

473.0

793.5

0.60

117

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

130

1.07

0.04

1.0

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

503

4994

1.01

0.03

2.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

148

1493

0.99

0.03

3.5

—

(3011985) Renin [Units/volume] in Plasma

125

1262

0.99

0.03

2.2

1.8

mu/l

50.6

55.5

0.14

116

1159

(3034770) Mitochondria Ab [Titer] in Serum

282

2795

1.01

0.03

1.3

titre

1226.9

857.1

0.51

113

(3048879) Bone marrow aspiration report

118

0.93

0.03

2.2

2.4

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

971

0.99

0.03

1.4

1.5

mmol/l

5.4

5.2

1.21

926

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

339

3364

1.01

0.02

1.1

u/ml

1.4

1.3

0.05

127

1248

(3029396) Erythrocyte agglutination [Presence] in Blood

830

0.99

0.02

3.0

3.2

—

(3045788) Cell count panel - Pleural fluid

310

1.03

0.02

1.3

1.5

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

469

1.02

0.02

1.6

1.4

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

519

0.98

0.02

1.1

1.2

106.6

110.5

0.44

472

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

549

0.98

0.02

1.0

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

668

1.02

0.02

1.0

1.1

nmol/l

0.3

3.4

1.49

121

(44790049)

857

1.01

0.02

1.3

1.4

—

(44806118)

857

1.01

0.02

1.3

1.4

—

(3024263) Appearance of Synovial fluid

348

0.97

0.02

2.1

2.0

—

(3023199) Leukocytes [#/volume] in Pleural fluid

388

0.98

0.02

1.3

1.4

e6/l

11468.8

2787.7

0.47

281

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

468

0.98

0.02

1.5

1.6

u/field

2.1

2.2

0.04

341

(44790047)

858

1.01

0.02

1.3

1.4

—

(44790048)

858

1.01

0.02

1.3

1.4

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

709

1.01

0.02

1.8

1.6

—

(3036489) Thrombin time

397

3947

1.00

0.02

1.8

1.9

20.7

0.06

335

3259

(3027273) Bicarbonate [Moles/volume] in Venous blood

257

2577

1.00

0.01

2.8

2.9

mmol/l

25.5

25.3

0.61

249

2485

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

187

0.96

0.01

1.3

1.6

ug/l

0.5

0.4

0.19

130

(3000012) Reticulocyte production index

332

1.02

0.01

1.1

1.4

—

(40767503) Oxygen content in Capillary blood by calculation

138

1386

0.99

0.01

2.7

2.1

17.1

16.9

0.30

673

(3047007) Chlamydophila sp Ab [Presence] in Serum

209

2076

1.00

0.01

1.2

—

(3042517) Benzodiazepines panel - Urine

213

1.03

0.01

2.7

2.6

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

209

2094

1.00

0.01

1.3

1.2

u/ml

2.8

4.0

2.03

858

(3042631) Mycobacterium sp identified in Specimen

672

1.01

0.00

2.4

2.5

—

(3033799) Differential panel - Peritoneal fluid

166

1.02

0.00

2.2

1.9

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

185

1.02

0.00

3.1

3.0

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

185

1.02

0.00

3.1

3.0

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

356

1.01

0.00

1.0

mg/g

5.0

5.1

0.04

331

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

459

1.00

0.00

1.2

1.4

pmol/l

13.8

13.4

0.20

378

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

789

1.00

0.00

1.6

1.7

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

896

1.00

0.00

1.8

1.6

46.3

48.3

0.19

550

(21494434) Karyotype in Bone marrow

431

1.00

0.00

1.0

1.2

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

112

1120

1.00

0.00

1.8

1.6

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

134

0.97

0.00

1.2

1.6

ng/l

139.0

55.6

—

(44806071)

197

1.01

0.00

1.1

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

720

1.00

0.00

1.5

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

676

1.00

0.00

1.7

1.6

39.8

40.2

0.03

405

(3013637) Mi-2 Ab [Presence] in Serum

235

1.02

0.00

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

235

1.02

0.00

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

235

1.02

0.00

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

235

1.02

0.00

1.1

—

(3028717) Thiamine [Mass/volume] in Blood

127

1.02

0.00

1.4

1.2

—

(3016031) Almond IgE Ab [Units/volume] in Serum

127

1.02

0.00

1.0

u/ml

0.1

0.4

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

140

1.00

0.00

1.1

1.0

—

(4133840)

242

0.99

0.00

1.1

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

171

0.99

0.00

2.6

1.9

e6/l

1036.6

19518.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

212

0.99

0.00

1.2

1.4

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

202

0.99

0.00

1.1

1.0

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

507

1.00

0.00

1.3

1.2

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

141

1403

1.00

0.00

1.2

1.3

—

(3036603) Volume of Urine

552

0.99

0.00

1.4

1.6

1639.2

2063.2

—

103

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

576

1.00

0.00

1.3

1.2

55.4

69.9

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

117

1171

1.00

0.00

1.1

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

341

0.99

0.00

1.3

1.2

nmol/l

5.9

5.6

0.18

319

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

298

1.00

0.00

1.4

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

298

1.00

0.00

1.4

1.3

—

(40757494) Bilirubin.total [Moles/volume] in Blood

316

1.01

0.00

2.5

2.3

umol/l

12.2

15.5

—

(3012441) Differential panel - Pleural fluid

312

0.99

0.00

1.4

1.5

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

0.94

0.00

1.3

1.1

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

0.95

0.00

1.0

1.1

—

4.4

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

0.89

0.00

1.6

1.3

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

0.91

0.00

1.2

—

(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline

0.00

0.0

1.0

—

299.4

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

0.94

0.00

1.0

1.3

—

(43055189) Lymphocytes [#/area] in Urine sediment by Microscopy high power field

0.00

0.0

1.0

—

(3000285) Sodium [Moles/volume] in Blood

0.91

0.00

1.0

1.1

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

0.92

0.00

1.0

1.1

—

(3042628) Porphyrins [Moles/volume] in Urine

0.00

0.0

1.0

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.0

1.0

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.0

1.0

—

(3007147) Virus identified in Stool by Electron microscopy

0.00

0.0

1.0

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

0.92

0.00

12.1

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

0.98

0.00

3.2

3.1

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

0.00

0.0

1.0

—

23.3

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

0.0

1.0

—

1.1

—

(3014171) Thiocyanate [Moles/volume] in Serum or Plasma

0.00

0.0

1.5

—

145.3

—

(3033463) Neutrophils [#/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.01

0.00

1.0

1.2

—

(3002853) Influenza virus B Ab [Titer] in Serum

0.00

0.0

1.0

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3009992) Blasts/100 cells in Bone marrow

0.00

0.0

2.5

—

5.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint N14_CERVICAL_DYSPLASIA_ALL and mortality.

Females

Parameter	HR [95% CI]	p-value
N14_CERVICAL_DYSPLASIA_ALL	1.091 [0.96, 1.24]	0.167
Birth year	0.993 [0.98, 1.0]	0.085

During the follow-up period (1.1.1998 — 31.12.2019), 1991 out of 62972 females with N14_CERVICAL_DYSPLASIA_ALL died.

Males

No data

Mortality risk

Mortality risk for people of age

years, who have N14_CERVICAL_DYSPLASIA_ALL.

N-year risk	Females	Males
1	0.083%	No data
5	0.599%	No data
10	1.599%	No data
15	3.141%	No data
20	5.265%	No data

Relationships between endpoints

↥

Index endpoint: N14_CERVICAL_DYSPLASIA_ALL – All dysplastic lesions of the cervix uteri

GWS hits: 3

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

All dysplastic lesions of the cervix uteri

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints